data_2gcz_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2gcz _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 87.2 m . . . . . 0 N--CA 1.468 0.438 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.5 p -99.06 24.47 7.79 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.703 0.287 . . . . 0.0 111.739 177.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -134.88 129.4 19.17 Favored Pre-proline 0 C--O 1.232 0.174 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.354 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -54.88 -37.1 93.03 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.104 2.536 . . . . 0.0 113.124 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.57 -36.62 70.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.882 0.372 . . . . 0.0 111.18 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.45 ' HA ' HD22 ' A' ' 11' ' ' ASN . 45.7 t -72.93 -19.2 61.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.601 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -82.55 -11.31 58.54 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.081 176.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.1 t -79.47 -53.08 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.716 0.293 . . . . 0.0 110.459 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.45 HD22 ' HA ' ' A' ' 8' ' ' CYS . 9.6 p30 -74.09 -26.71 60.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.05 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.667 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 72.6 m-20 -119.68 78.93 22.41 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.738 174.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 11' ' ' ASN . 10.1 Cg_exo -77.9 -59.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.924 2.416 . . . . 0.0 114.475 -170.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -97.92 -6.62 31.88 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.508 -172.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.45 HD11 HG22 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -99.37 -30.72 3.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.857 176.858 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.667 ' HB3' ' HB3' ' A' ' 12' ' ' ASN . 52.4 t -127.35 -15.83 5.06 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.173 -170.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.357 -0.925 . . . . 0.0 111.819 177.757 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 97.0 m . . . . . 0 N--CA 1.462 0.172 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.4 p -99.65 16.66 22.75 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.143 0.497 . . . . 0.0 110.408 173.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -125.77 130.55 24.01 Favored Pre-proline 0 C--O 1.233 0.227 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.049 -175.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -52.34 -46.27 34.02 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.325 2.684 . . . . 0.0 113.518 -175.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.98 -44.97 94.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.838 0.351 . . . . 0.0 111.456 -178.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.504 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 11.9 m -71.9 -15.78 62.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.243 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -85.51 -25.69 26.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.664 0.268 . . . . 0.0 111.002 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.0 t -82.08 -52.44 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.367 178.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.423 ' N ' HD21 ' A' ' 11' ' ' ASN . 2.6 m120 -67.43 -31.18 71.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.564 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.628 ' HB2' ' HB3' ' A' ' 16' ' ' CYS . 5.1 m120 -119.4 77.29 18.6 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 177.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -83.57 -42.19 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.375 2.05 . . . . 0.0 115.088 -168.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 34.1 p-80 -98.38 -16.36 19.33 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.223 0.535 . . . . 0.0 110.96 -175.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.526 HG21 HD11 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -98.3 -28.71 3.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.079 -179.461 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.628 ' HB3' ' HB2' ' A' ' 12' ' ' ASN . 42.6 t -130.36 -26.9 2.26 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.379 -169.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.391 0 C-N-CA 120.249 -0.977 . . . . 0.0 112.339 -178.244 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 55.8 m . . . . . 0 N--CA 1.464 0.225 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.1 m -98.74 17.04 20.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.131 0.491 . . . . 0.0 110.36 175.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -128.33 128.58 23.65 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.021 -175.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.06 -42.31 67.85 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.878 2.385 . . . . 0.0 113.166 -176.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.04 -42.86 99.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.971 0.415 . . . . 0.0 111.328 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 66.1 m -68.93 -25.13 64.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.899 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -77.93 -29.95 50.23 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.619 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 85.7 t -68.03 -50.14 61.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.113 0.483 . . . . 0.0 109.878 175.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.416 HD21 ' N ' ' A' ' 11' ' ' ASN . 2.3 m120 -68.25 -30.08 69.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.111 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.553 ' O ' ' HB3' ' A' ' 16' ' ' CYS . 69.2 m-80 -125.6 78.42 68.6 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.719 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -89.2 -26.47 0.46 Allowed 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 122.49 2.127 . . . . 0.0 114.31 -173.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -100.01 -26.61 13.92 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.882 0.372 . . . . 0.0 111.95 -173.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.1 pt -99.46 -34.39 4.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.257 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.553 ' HB3' ' O ' ' A' ' 12' ' ' ASN . 40.6 t -111.34 -64.19 1.31 Allowed 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.938 -1.028 . . . . 0.0 112.154 -166.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.421 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.662 -177.995 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 86.3 m . . . . . 0 N--CA 1.464 0.237 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.6 t -98.93 15.12 26.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.987 0.422 . . . . 0.0 110.101 175.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -129.61 132.53 24.27 Favored Pre-proline 0 CA--C 1.518 -0.258 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.544 -175.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.547 ' O ' HG22 ' A' ' 10' ' ' VAL . 51.7 Cg_exo -55.6 -47.11 27.24 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.927 2.418 . . . . 0.0 112.996 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.51 -40.02 95.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.855 0.359 . . . . 0.0 111.398 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.6 t -69.61 -27.17 64.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.736 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -77.37 -23.86 50.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.87 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 6' ' ' PRO . 72.2 t -77.3 -50.93 19.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.778 0.323 . . . . 0.0 110.23 177.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.446 HD21 ' N ' ' A' ' 11' ' ' ASN . 2.2 m120 -69.24 -27.73 65.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.75 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.543 ' CB ' ' HB3' ' A' ' 16' ' ' CYS . 74.6 m-20 -122.21 77.14 42.92 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.482 177.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -87.49 -38.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.185 1.923 . . . . 0.0 114.978 -168.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -98.77 -9.21 24.77 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.376 0.608 . . . . 0.0 111.276 -174.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.9 pt -108.45 -41.02 4.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.583 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.543 ' HB3' ' CB ' ' A' ' 12' ' ' ASN . 44.7 t -115.04 -26.99 7.5 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.583 -170.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.419 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.378 -179.156 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 84.8 m . . . . . 0 N--CA 1.458 -0.067 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 54.9 m -98.51 23.79 8.15 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.123 0.487 . . . . 0.0 110.574 174.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.423 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . 9.6 m80 -130.37 118.21 18.06 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.829 -176.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 5' ' ' HIS . 3.8 Cg_endo -51.01 -47.05 27.46 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.441 2.761 . . . . 0.0 113.631 -174.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.02 -41.43 95.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.798 0.333 . . . . 0.0 111.215 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.572 ' HA ' HD22 ' A' ' 11' ' ' ASN . 39.8 t -66.82 -26.38 66.9 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.167 178.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -72.83 -15.11 61.63 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.672 0.272 . . . . 0.0 111.122 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.412 ' O ' ' HG3' ' A' ' 13' ' ' PRO . 59.6 t -83.28 -49.05 17.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.621 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.572 HD22 ' HA ' ' A' ' 8' ' ' CYS . 11.7 p30 -78.75 -21.54 47.81 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.816 0.341 . . . . 0.0 110.86 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.657 ' HB3' ' CB ' ' A' ' 16' ' ' CYS . 37.4 m-20 -122.23 74.81 40.83 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.156 174.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.424 ' HD3' ' C ' ' A' ' 11' ' ' ASN . 10.3 Cg_exo -77.55 -58.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.028 2.486 . . . . 0.0 113.946 -172.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 49.6 p-80 -98.38 -12.45 21.42 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.481 -175.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -97.97 -2.74 9.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.914 0.388 . . . . 0.0 110.27 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.657 ' CB ' ' HB3' ' A' ' 12' ' ' ASN . 52.5 t -143.83 -67.98 0.34 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.079 -175.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 C-N-CA 120.005 -1.093 . . . . 0.0 112.663 -175.756 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 67.9 m . . . . . 0 N--CA 1.467 0.376 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.0 t -99.17 5.71 46.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.055 0.455 . . . . 0.0 110.226 175.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -121.62 132.82 24.15 Favored Pre-proline 0 C--O 1.232 0.134 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.715 -174.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -54.8 -39.63 88.86 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.176 2.584 . . . . 0.0 113.501 -177.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.552 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -65.73 -39.5 91.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.887 0.375 . . . . 0.0 111.262 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.509 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 46.9 m -73.2 -23.11 60.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.532 178.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -85.12 -22.85 28.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.292 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.552 HG12 ' O ' ' A' ' 7' ' ' ALA . 6.2 p -85.67 -36.11 10.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.723 0.297 . . . . 0.0 110.451 -178.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.449 HD21 ' N ' ' A' ' 11' ' ' ASN . 2.2 m120 -74.61 -20.12 60.04 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 173.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.673 ' CB ' ' HB3' ' A' ' 16' ' ' CYS . 73.0 m-80 -135.41 73.64 62.58 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.678 -177.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -76.8 -43.26 0.27 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.827 2.351 . . . . 0.0 114.309 -173.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 -97.77 -17.02 19.61 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -173.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.489 HG12 ' HB3' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -99.38 -30.58 3.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.098 0.475 . . . . 0.0 110.966 179.492 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.673 ' HB3' ' CB ' ' A' ' 12' ' ' ASN . 43.5 t -130.63 -3.38 4.2 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.832 -170.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.429 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.262 178.77 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 69.6 m . . . . . 0 CA--C 1.528 0.11 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.5 t -99.43 18.27 18.2 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.265 0.555 . . . . 0.0 109.61 174.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.2 m80 -131.3 123.24 19.51 Favored Pre-proline 0 C--N 1.334 -0.095 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.36 -174.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_exo -49.26 -42.51 40.01 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.305 2.67 . . . . 0.0 113.322 -178.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.64 -46.48 87.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.197 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.58 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 24.3 m -76.35 -11.99 59.99 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.29 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -83.78 -32.71 25.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.894 0.378 . . . . 0.0 110.172 177.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 51.2 t -84.86 -46.86 17.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.52 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.426 ' N ' HD21 ' A' ' 11' ' ' ASN . 2.4 m120 -69.04 -32.69 72.36 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.096 0.474 . . . . 0.0 110.364 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.58 ' HB2' ' O ' ' A' ' 8' ' ' CYS . 7.2 m120 -118.09 77.72 12.76 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.422 176.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -88.57 -33.65 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.23 1.954 . . . . 0.0 114.323 -170.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -98.41 -13.29 20.68 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.353 -175.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.486 HG12 ' HB3' ' A' ' 12' ' ' ASN . 0.1 OUTLIER -106.97 -32.1 2.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.195 0.521 . . . . 0.0 110.695 176.047 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.58 ' HB3' ' HB2' ' A' ' 12' ' ' ASN . 34.9 t -126.56 11.35 7.34 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.658 -169.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.396 0 C-N-CA 120.403 -0.904 . . . . 0.0 112.035 179.384 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 80.2 m . . . . . 0 N--CA 1.455 -0.185 0 CA-C-O 120.823 0.344 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.0 m -104.8 6.52 34.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.249 176.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -127.82 133.37 25.04 Favored Pre-proline 0 C--O 1.232 0.14 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 -176.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.4 ' O ' HG21 ' A' ' 10' ' ' VAL . 24.3 Cg_endo -61.64 -34.17 84.9 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.381 2.054 . . . . 0.0 112.036 177.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.85 -44.95 79.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.123 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 47.1 t -68.52 -27.33 66.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.574 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -71.68 -22.06 61.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.846 176.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 6' ' ' PRO . 93.7 t -73.47 -51.34 25.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.73 0.3 . . . . 0.0 110.346 176.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.458 HD21 ' N ' ' A' ' 11' ' ' ASN . 2.1 m120 -71.02 -31.86 68.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.201 0.524 . . . . 0.0 110.526 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.584 ' O ' ' HB3' ' A' ' 16' ' ' CYS . 74.4 m-80 -119.56 77.5 20.08 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.401 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -90.13 -36.74 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.73 2.287 . . . . 0.0 114.057 -174.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 32.5 p-80 -99.79 -17.63 17.58 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.848 0.356 . . . . 0.0 111.314 -176.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.38 -31.95 3.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.31 0.576 . . . . 0.0 111.127 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.584 ' HB3' ' O ' ' A' ' 12' ' ' ASN . 36.2 t -116.02 -74.58 0.6 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.835 -170.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.422 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.421 -179.063 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 75.4 m . . . . . 0 CA--C 1.524 -0.048 0 CA-C-O 120.826 0.346 . . . . 0.0 111.486 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 37.2 m -99.9 8.19 44.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.071 177.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -125.11 134.37 25.67 Favored Pre-proline 0 C--O 1.232 0.161 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 -175.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -52.43 -53.02 7.61 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.062 2.508 . . . . 0.0 113.497 -177.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.09 -38.05 87.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.661 -178.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.0 t -68.12 -28.55 67.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.872 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -75.07 -22.37 58.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.326 177.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 56.1 t -77.64 -56.47 7.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.854 0.359 . . . . 0.0 110.581 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -66.83 -24.87 66.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.88 0.372 . . . . 0.0 111.16 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.483 ' CB ' ' HB3' ' A' ' 16' ' ' CYS . 73.5 m-80 -122.88 78.62 49.82 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.12 178.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -96.3 -25.73 0.1 Allowed 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.663 2.242 . . . . 0.0 115.081 -170.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -98.46 -21.82 16.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.29 0.567 . . . . 0.0 111.093 -176.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.5 pt -105.22 -37.07 3.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.643 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.483 ' HB3' ' CB ' ' A' ' 12' ' ' ASN . 42.8 t -117.68 -12.18 10.31 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.746 -1.115 . . . . 0.0 111.05 -170.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.248 -179.189 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 72.1 m . . . . . 0 N--CA 1.463 0.21 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.2 t -98.63 22.84 9.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.999 0.428 . . . . 0.0 110.291 177.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -131.74 124.21 19.7 Favored Pre-proline 0 C--O 1.231 0.089 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.24 -176.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -55.41 -40.48 85.3 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.149 2.566 . . . . 0.0 113.54 -176.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.49 -34.39 70.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.846 0.355 . . . . 0.0 110.873 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 42.6 t -71.03 -24.4 62.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.173 0.511 . . . . 0.0 110.666 178.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -79.52 -12.3 59.87 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.136 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.7 t -77.42 -58.34 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.731 0.3 . . . . 0.0 110.369 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -76.04 -12.13 60.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.819 0.343 . . . . 0.0 111.152 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.623 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 82.3 m-20 -128.55 72.42 80.71 Favored Pre-proline 0 N--CA 1.465 0.285 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.133 174.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -83.16 -43.84 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.43 2.086 . . . . 0.0 114.913 -170.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -97.74 -19.0 18.49 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.909 0.385 . . . . 0.0 111.915 -171.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.9 pt -99.07 -32.35 3.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.041 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.623 ' HB3' ' HB3' ' A' ' 12' ' ' ASN . 22.3 t -127.67 -13.05 5.4 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.508 -169.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 C-N-CA 120.344 -0.931 . . . . 0.0 112.454 -177.632 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 87.8 m . . . . . 0 N--CA 1.462 0.148 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.5 p -98.96 14.72 28.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.939 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 21.9 m80 -131.26 142.73 46.52 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.926 -176.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.46 ' O ' HG23 ' A' ' 10' ' ' VAL . 46.6 Cg_exo -57.71 -51.13 8.74 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.9 2.4 . . . . 0.0 113.21 -178.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.22 -45.69 92.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.744 -177.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.3 t -64.92 -28.23 69.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.877 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -73.39 -29.91 62.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.656 176.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 6' ' ' PRO . 64.4 t -73.58 -48.48 40.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.208 178.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -61.77 -42.18 98.66 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.598 178.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.543 ' CB ' ' HB3' ' A' ' 16' ' ' CYS . 4.9 m120 -115.01 78.7 5.65 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.002 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -64.59 -68.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.715 2.277 . . . . 0.0 113.857 -172.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -98.35 2.03 47.59 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.077 0.465 . . . . 0.0 111.31 -175.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.0 mp -99.15 -18.09 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.449 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.543 ' HB3' ' CB ' ' A' ' 12' ' ' ASN . 21.9 t -140.69 -36.09 0.47 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.598 -172.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.204 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.532 -177.623 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 44.5 m . . . . . 0 N--CA 1.468 0.449 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 p -98.85 15.31 25.9 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.97 0.414 . . . . 0.0 110.961 175.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.1 m80 -128.54 132.79 24.56 Favored Pre-proline 0 CA--C 1.519 -0.213 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.795 -175.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -51.52 -42.35 56.09 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.215 2.61 . . . . 0.0 113.388 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.571 ' O ' HG11 ' A' ' 10' ' ' VAL . . . -65.69 -42.88 90.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.85 0.357 . . . . 0.0 111.3 -179.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.53 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 79.4 m -69.61 -20.58 63.62 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.81 0.338 . . . . 0.0 110.938 178.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -85.57 -23.88 27.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.447 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.571 HG11 ' O ' ' A' ' 7' ' ' ALA . 6.2 p -84.64 -40.12 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.265 -176.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -80.21 -9.27 59.72 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.263 0.554 . . . . 0.0 110.166 175.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.583 ' CB ' ' HB3' ' A' ' 16' ' ' CYS . 68.4 m-80 -137.06 67.05 55.39 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.09 178.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -84.72 -30.5 0.57 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.285 1.99 . . . . 0.0 113.99 -172.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -99.35 -23.26 15.22 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.888 0.375 . . . . 0.0 111.582 -174.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.537 HG13 ' H ' ' A' ' 16' ' ' CYS . 5.2 pt -98.47 -46.77 12.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.481 0.657 . . . . 0.0 110.738 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.583 ' HB3' ' CB ' ' A' ' 12' ' ' ASN . 16.8 t -98.86 -27.53 13.87 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.985 -173.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.399 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.912 177.599 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.3 m . . . . . 0 N--CA 1.461 0.082 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 45.3 m -98.74 18.71 16.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.931 0.395 . . . . 0.0 110.745 176.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.3 m80 -127.09 124.43 23.85 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.604 -174.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.48 ' O ' HG21 ' A' ' 10' ' ' VAL . 61.7 Cg_exo -54.05 -40.0 83.18 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.171 2.58 . . . . 0.0 113.383 -176.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.53 -43.23 97.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.866 0.365 . . . . 0.0 111.27 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.4 m -69.86 -25.01 63.52 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.056 0.455 . . . . 0.0 110.291 178.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -78.75 -13.13 59.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.013 178.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.48 HG21 ' O ' ' A' ' 6' ' ' PRO . 60.5 t -75.01 -52.75 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 175.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.455 ' N ' HD21 ' A' ' 11' ' ' ASN . 2.2 m120 -70.49 -31.71 68.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.559 178.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.5 ' CB ' ' HB3' ' A' ' 16' ' ' CYS . 74.7 m-80 -124.63 76.47 63.92 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.649 -178.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.642 ' HD2' HD13 ' A' ' 15' ' ' ILE . 36.6 Cg_endo -75.57 -59.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.64 2.227 . . . . 0.0 114.545 -172.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 24.5 p80 -98.46 -4.76 33.79 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.057 0.456 . . . . 0.0 111.172 -174.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.642 HD13 ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -98.61 -22.84 4.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.575 178.479 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.5 ' HB3' ' CB ' ' A' ' 12' ' ' ASN . 50.7 t -137.92 -17.31 1.24 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.863 -170.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.147 178.03 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 71.6 m . . . . . 0 N--CA 1.462 0.163 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.8 p -98.86 21.11 11.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.042 0.449 . . . . 0.0 110.66 174.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.405 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 2.8 m80 -127.31 131.15 23.7 Favored Pre-proline 0 C--O 1.233 0.193 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.181 -175.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.538 ' O ' HG22 ' A' ' 10' ' ' VAL . 64.9 Cg_exo -53.2 -49.53 17.16 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.0 2.467 . . . . 0.0 113.026 -178.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.56 -39.13 86.84 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.061 -178.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.405 ' SG ' ' HB2' ' A' ' 5' ' ' HIS . 36.8 m -70.32 -29.01 65.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.87 0.367 . . . . 0.0 110.606 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -76.62 -20.18 57.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.291 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.538 HG22 ' O ' ' A' ' 6' ' ' PRO . 57.7 t -69.96 -51.8 36.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.929 0.395 . . . . 0.0 110.427 178.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -74.69 -32.02 62.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.149 0.5 . . . . 0.0 110.987 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.545 ' O ' ' HB3' ' A' ' 16' ' ' CYS . 74.4 m-80 -120.59 77.19 27.8 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.558 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -85.28 -42.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.1 2.533 . . . . 0.0 113.912 -172.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -98.05 -16.29 19.66 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.882 0.372 . . . . 0.0 111.362 -174.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.66 -27.66 3.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.006 178.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.545 ' HB3' ' O ' ' A' ' 12' ' ' ASN . 50.8 t -130.49 -6.69 4.19 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.079 -169.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 C-N-CA 120.166 -1.016 . . . . 0.0 112.262 179.109 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 92.2 m . . . . . 0 N--CA 1.463 0.187 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 p -99.04 18.39 17.44 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.727 0.299 . . . . 0.0 110.66 174.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.5 m80 -130.75 136.29 28.7 Favored Pre-proline 0 C--O 1.234 0.238 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.546 -176.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -56.93 -40.93 80.54 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 123.035 2.49 . . . . 0.0 113.244 -178.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.584 ' O ' HG11 ' A' ' 10' ' ' VAL . . . -69.52 -37.21 77.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.206 -178.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.552 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 80.1 m -71.69 -22.3 61.67 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.793 0.33 . . . . 0.0 110.888 177.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -82.93 -25.2 32.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.93 179.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.584 HG11 ' O ' ' A' ' 7' ' ' ALA . 5.0 p -85.79 -39.62 13.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.361 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.417 HD21 ' N ' ' A' ' 11' ' ' ASN . 2.2 m120 -71.02 -16.49 62.62 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.053 0.454 . . . . 0.0 110.345 174.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.617 ' CB ' ' HB3' ' A' ' 16' ' ' CYS . 70.9 m-80 -137.7 77.63 38.7 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.298 -179.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -65.72 -66.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.167 2.578 . . . . 0.0 114.504 -172.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -97.48 -2.41 42.06 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.921 0.391 . . . . 0.0 111.486 -172.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.38 -25.82 3.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.893 178.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.617 ' HB3' ' CB ' ' A' ' 12' ' ' ASN . 36.9 t -136.52 -28.23 1.01 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.329 -169.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.275 -179.377 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 67.6 m . . . . . 0 N--CA 1.463 0.181 0 CA-C-O 120.706 0.289 . . . . 0.0 111.601 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.2 p -98.71 17.31 19.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.525 175.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.1 m80 -127.64 131.96 24.09 Favored Pre-proline 0 N--CA 1.462 0.125 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.424 -175.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.47 ' O ' HG21 ' A' ' 10' ' ' VAL . 9.8 Cg_endo -57.83 -41.42 69.73 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.195 2.597 . . . . 0.0 113.444 -175.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.18 -42.22 93.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.077 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 58.9 m -66.45 -22.35 66.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.102 0.477 . . . . 0.0 110.648 177.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -85.43 -6.85 59.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.42 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.47 HG21 ' O ' ' A' ' 6' ' ' PRO . 48.4 t -82.12 -55.02 8.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 176.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -75.73 -20.78 58.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.178 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.54 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 71.9 m-20 -125.34 79.56 66.39 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.15 174.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -79.91 -56.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.021 2.481 . . . . 0.0 114.915 -170.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 23.2 p-80 -97.55 -10.11 25.83 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.575 -172.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -98.3 -31.73 3.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.259 0.552 . . . . 0.0 110.574 179.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.54 ' HB3' ' HB3' ' A' ' 12' ' ' ASN . 50.6 t -122.08 -19.07 6.73 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.085 -170.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.399 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.167 178.108 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.9 m . . . . . 0 N--CA 1.467 0.383 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.1 p -99.59 20.44 13.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.808 0.337 . . . . 0.0 111.576 176.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 6.0 m80 -127.48 137.78 31.43 Favored Pre-proline 0 N--CA 1.462 0.166 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.225 -176.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -54.41 -48.57 20.77 Favored 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 123.033 2.488 . . . . 0.0 113.504 -176.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.547 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -67.92 -36.53 80.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.103 -178.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.597 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 62.5 m -68.75 -29.2 67.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.715 178.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -80.15 -30.95 38.97 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 7' ' ' ALA . 9.1 p -78.24 -37.72 22.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.949 -176.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -83.69 -1.17 53.49 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.896 0.379 . . . . 0.0 110.571 175.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.707 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 70.4 m-80 -141.13 71.4 27.89 Favored Pre-proline 0 N--CA 1.467 0.423 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.135 177.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -79.82 -44.57 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.767 2.311 . . . . 0.0 114.479 -170.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 30.2 p-80 -98.34 -15.09 19.87 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.803 0.335 . . . . 0.0 111.413 -174.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.455 HD13 HG21 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -99.3 -30.05 3.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.246 -179.147 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.707 ' HB3' ' HB3' ' A' ' 12' ' ' ASN . 33.7 t -130.06 -22.01 2.91 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.41 -169.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.26 -179.214 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 85.4 m . . . . . 0 N--CA 1.464 0.25 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.1 m -98.55 23.26 8.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.806 0.336 . . . . 0.0 110.737 175.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.0 m80 -132.48 129.4 21.44 Favored Pre-proline 0 C--O 1.233 0.2 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.38 -176.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.422 ' O ' HG21 ' A' ' 10' ' ' VAL . 86.7 Cg_exo -49.04 -43.08 37.31 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.307 2.671 . . . . 0.0 113.475 -177.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.46 -46.39 90.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.362 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.501 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 82.1 m -71.46 -15.72 62.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.749 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -85.19 -30.74 23.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.752 0.31 . . . . 0.0 110.666 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.422 HG21 ' O ' ' A' ' 6' ' ' PRO . 48.8 t -82.99 -48.69 17.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.243 177.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -65.48 -34.08 77.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.256 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.639 ' HB2' ' HB3' ' A' ' 16' ' ' CYS . 6.2 m120 -123.69 79.46 55.92 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.801 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -81.67 -42.88 0.1 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.351 2.034 . . . . 0.0 114.688 -170.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 27.2 p80 -98.56 -13.41 20.44 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.608 -173.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.491 HG12 ' HB3' ' A' ' 12' ' ' ASN . 0.1 OUTLIER -101.49 -32.83 3.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.72 176.716 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.639 ' HB3' ' HB2' ' A' ' 12' ' ' ASN . 20.0 t -127.12 2.67 6.46 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.675 -170.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.466 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.237 -179.462 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 95.3 m . . . . . 0 N--CA 1.464 0.247 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.8 p -98.87 18.97 15.83 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.788 175.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.9 m80 -129.99 131.55 23.55 Favored Pre-proline 0 C--O 1.232 0.176 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.229 -177.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.4 ' O ' HG21 ' A' ' 10' ' ' VAL . 77.3 Cg_exo -52.89 -52.93 7.71 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.097 2.531 . . . . 0.0 113.574 -176.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.78 -39.44 94.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.45 -178.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.8 t -64.79 -26.59 68.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.019 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -78.15 -22.96 47.96 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.273 177.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 6' ' ' PRO . 59.9 t -79.17 -48.88 20.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.884 0.373 . . . . 0.0 110.702 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -73.05 -27.76 61.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.987 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.547 ' CB ' ' HB3' ' A' ' 16' ' ' CYS . 76.9 m-20 -119.58 80.4 23.02 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.824 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -91.1 -38.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.891 2.394 . . . . 0.0 114.4 -172.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 56.1 p-80 -98.53 -12.45 21.22 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.762 -177.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.53 HG12 ' HB3' ' A' ' 12' ' ' ASN . 0.1 OUTLIER -101.84 -31.67 3.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.488 176.092 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.547 ' HB3' ' CB ' ' A' ' 12' ' ' ASN . 44.9 t -131.73 17.25 4.75 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.553 -170.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.235 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.167 178.314 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 94.2 m . . . . . 0 N--CA 1.463 0.19 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.1 m -99.79 12.06 37.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.563 0.221 . . . . 0.0 111.048 176.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.4 m80 -124.4 127.48 25.26 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.795 -174.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -55.04 -38.07 93.58 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.271 2.647 . . . . 0.0 113.925 -175.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.668 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -67.9 -43.04 80.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.099 0.476 . . . . 0.0 110.777 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.657 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 52.6 t -70.28 -19.58 63.09 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.621 178.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -83.24 -17.8 41.41 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.668 HG12 ' O ' ' A' ' 7' ' ' ALA . 4.8 p -84.04 -41.18 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.116 -176.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -88.83 -5.79 57.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.006 0.432 . . . . 0.0 110.126 175.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.691 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 74.7 m-20 -135.61 71.45 65.15 Favored Pre-proline 0 N--CA 1.465 0.292 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.199 174.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -85.69 -42.43 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.901 2.401 . . . . 0.0 114.088 -172.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 -98.21 -15.95 19.66 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.044 0.449 . . . . 0.0 111.079 -176.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.17 -30.58 3.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.894 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.691 ' HB3' ' HB3' ' A' ' 12' ' ' ASN . 35.4 t -134.63 4.14 3.33 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.479 -170.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.48 0 C-N-CA 120.397 -0.906 . . . . 0.0 111.95 179.151 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.887 0 N-CA-C 111.658 -0.577 . . . . 0.0 111.658 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 11.2 t -102.95 -32.16 9.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 117.064 0.432 . . . . 0.0 110.503 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 87.2 m -64.58 -2.66 2.51 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.5 p -99.06 24.47 7.79 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.703 0.287 . . . . 0.0 111.739 177.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -134.88 129.4 19.17 Favored Pre-proline 0 C--O 1.232 0.174 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.354 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -54.88 -37.1 93.03 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.104 2.536 . . . . 0.0 113.124 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.57 -36.62 70.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.882 0.372 . . . . 0.0 111.18 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.45 ' HA ' HD22 ' A' ' 11' ' ' ASN . 45.7 t -72.93 -19.2 61.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.601 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -82.55 -11.31 58.54 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.081 176.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.1 t -79.47 -53.08 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.716 0.293 . . . . 0.0 110.459 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.45 HD22 ' HA ' ' A' ' 8' ' ' CYS . 9.6 p30 -74.09 -26.71 60.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.05 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.667 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 72.6 m-20 -119.68 78.93 22.41 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.738 174.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 11' ' ' ASN . 10.1 Cg_exo -77.9 -59.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.924 2.416 . . . . 0.0 114.475 -170.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -97.92 -6.62 31.88 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.508 -172.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.45 HD11 HG22 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -99.37 -30.72 3.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.857 176.858 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.667 ' HB3' ' HB3' ' A' ' 12' ' ' ASN . 52.4 t -127.35 -15.83 5.06 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.173 -170.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.33 -27.68 3.3 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.357 -0.925 . . . . 0.0 111.819 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.554 0 O-C-N 121.913 -0.757 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.929 0 N-CA-C 111.961 -0.455 . . . . 0.0 111.961 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 4.8 p 40.13 51.87 2.69 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.395 0.678 . . . . 0.0 112.382 178.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 97.0 m -75.99 0.15 19.53 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -177.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.4 p -99.65 16.66 22.75 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.143 0.497 . . . . 0.0 110.408 173.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -125.77 130.55 24.01 Favored Pre-proline 0 C--O 1.233 0.227 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.049 -175.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -52.34 -46.27 34.02 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.325 2.684 . . . . 0.0 113.518 -175.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.98 -44.97 94.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.838 0.351 . . . . 0.0 111.456 -178.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.504 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 11.9 m -71.9 -15.78 62.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.243 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -85.51 -25.69 26.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.664 0.268 . . . . 0.0 111.002 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.0 t -82.08 -52.44 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.367 178.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.423 ' N ' HD21 ' A' ' 11' ' ' ASN . 2.6 m120 -67.43 -31.18 71.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.564 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.628 ' HB2' ' HB3' ' A' ' 16' ' ' CYS . 5.1 m120 -119.4 77.29 18.6 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 177.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -83.57 -42.19 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.375 2.05 . . . . 0.0 115.088 -168.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 34.1 p-80 -98.38 -16.36 19.33 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.223 0.535 . . . . 0.0 110.96 -175.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.526 HG21 HD11 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -98.3 -28.71 3.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.079 -179.461 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.628 ' HB3' ' HB2' ' A' ' 12' ' ' ASN . 42.6 t -130.36 -26.9 2.26 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.379 -169.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.05 -128.61 4.93 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.249 -0.977 . . . . 0.0 112.339 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.547 0 O-C-N 121.911 -0.758 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.817 0 N-CA-C 112.121 -0.392 . . . . 0.0 112.121 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 2.6 p -134.17 53.84 1.98 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.12 0.486 . . . . 0.0 110.481 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 55.8 m -71.18 -0.16 9.13 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.1 m -98.74 17.04 20.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.131 0.491 . . . . 0.0 110.36 175.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -128.33 128.58 23.65 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.021 -175.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.06 -42.31 67.85 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.878 2.385 . . . . 0.0 113.166 -176.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.04 -42.86 99.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.971 0.415 . . . . 0.0 111.328 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 66.1 m -68.93 -25.13 64.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.899 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -77.93 -29.95 50.23 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.619 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 85.7 t -68.03 -50.14 61.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.113 0.483 . . . . 0.0 109.878 175.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.416 HD21 ' N ' ' A' ' 11' ' ' ASN . 2.3 m120 -68.25 -30.08 69.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.111 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.553 ' O ' ' HB3' ' A' ' 16' ' ' CYS . 69.2 m-80 -125.6 78.42 68.6 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.719 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -89.2 -26.47 0.46 Allowed 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 122.49 2.127 . . . . 0.0 114.31 -173.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -100.01 -26.61 13.92 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.882 0.372 . . . . 0.0 111.95 -173.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.1 pt -99.46 -34.39 4.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.257 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.553 ' HB3' ' O ' ' A' ' 12' ' ' ASN . 40.6 t -111.34 -64.19 1.31 Allowed 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.938 -1.028 . . . . 0.0 112.154 -166.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -140.15 79.29 0.29 Allowed Glycine 0 C--N 1.318 -0.421 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.662 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.553 0 O-C-N 121.755 -0.85 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.915 0 N-CA-C 112.1 -0.4 . . . . 0.0 112.1 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 12.6 t -67.78 -29.57 68.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.767 0.318 . . . . 0.0 110.487 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 86.3 m -71.19 6.71 1.54 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.6 t -98.93 15.12 26.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.987 0.422 . . . . 0.0 110.101 175.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -129.61 132.53 24.27 Favored Pre-proline 0 CA--C 1.518 -0.258 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.544 -175.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.547 ' O ' HG22 ' A' ' 10' ' ' VAL . 51.7 Cg_exo -55.6 -47.11 27.24 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.927 2.418 . . . . 0.0 112.996 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.51 -40.02 95.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.855 0.359 . . . . 0.0 111.398 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.6 t -69.61 -27.17 64.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.736 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -77.37 -23.86 50.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.87 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 6' ' ' PRO . 72.2 t -77.3 -50.93 19.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.778 0.323 . . . . 0.0 110.23 177.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.446 HD21 ' N ' ' A' ' 11' ' ' ASN . 2.2 m120 -69.24 -27.73 65.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.75 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.543 ' CB ' ' HB3' ' A' ' 16' ' ' CYS . 74.6 m-20 -122.21 77.14 42.92 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.482 177.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -87.49 -38.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.185 1.923 . . . . 0.0 114.978 -168.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -98.77 -9.21 24.77 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.376 0.608 . . . . 0.0 111.276 -174.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.9 pt -108.45 -41.02 4.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.583 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.543 ' HB3' ' CB ' ' A' ' 12' ' ' ASN . 44.7 t -115.04 -26.99 7.5 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.583 -170.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -99.37 -174.16 31.25 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.378 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.647 0 CA-C-N 117.737 0.768 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.885 0 N-CA-C 112.371 -0.292 . . . . 0.0 112.371 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.8 p -132.15 39.13 3.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.003 0.43 . . . . 0.0 110.783 178.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 84.8 m -73.37 -9.6 58.87 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 54.9 m -98.51 23.79 8.15 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.123 0.487 . . . . 0.0 110.574 174.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.423 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . 9.6 m80 -130.37 118.21 18.06 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.829 -176.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 5' ' ' HIS . 3.8 Cg_endo -51.01 -47.05 27.46 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.441 2.761 . . . . 0.0 113.631 -174.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.02 -41.43 95.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.798 0.333 . . . . 0.0 111.215 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.572 ' HA ' HD22 ' A' ' 11' ' ' ASN . 39.8 t -66.82 -26.38 66.9 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.167 178.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -72.83 -15.11 61.63 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.672 0.272 . . . . 0.0 111.122 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.412 ' O ' ' HG3' ' A' ' 13' ' ' PRO . 59.6 t -83.28 -49.05 17.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.621 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.572 HD22 ' HA ' ' A' ' 8' ' ' CYS . 11.7 p30 -78.75 -21.54 47.81 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.816 0.341 . . . . 0.0 110.86 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.657 ' HB3' ' CB ' ' A' ' 16' ' ' CYS . 37.4 m-20 -122.23 74.81 40.83 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.156 174.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.424 ' HD3' ' C ' ' A' ' 11' ' ' ASN . 10.3 Cg_exo -77.55 -58.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.028 2.486 . . . . 0.0 113.946 -172.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 49.6 p-80 -98.38 -12.45 21.42 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.481 -175.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -97.97 -2.74 9.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.914 0.388 . . . . 0.0 110.27 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.657 ' CB ' ' HB3' ' A' ' 12' ' ' ASN . 52.5 t -143.83 -67.98 0.34 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.079 -175.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -98.57 18.18 57.32 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.005 -1.093 . . . . 0.0 112.663 -175.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.676 0 O-C-N 121.81 -0.818 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.761 0 N-CA-C 112.097 -0.401 . . . . 0.0 112.097 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 4.6 p -115.57 50.41 1.01 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.958 0.408 . . . . 0.0 110.77 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 67.9 m -71.52 7.47 1.4 Allowed 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.0 t -99.17 5.71 46.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.055 0.455 . . . . 0.0 110.226 175.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -121.62 132.82 24.15 Favored Pre-proline 0 C--O 1.232 0.134 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.715 -174.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -54.8 -39.63 88.86 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.176 2.584 . . . . 0.0 113.501 -177.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.552 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -65.73 -39.5 91.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.887 0.375 . . . . 0.0 111.262 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.509 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 46.9 m -73.2 -23.11 60.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.532 178.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -85.12 -22.85 28.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.292 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.552 HG12 ' O ' ' A' ' 7' ' ' ALA . 6.2 p -85.67 -36.11 10.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.723 0.297 . . . . 0.0 110.451 -178.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.449 HD21 ' N ' ' A' ' 11' ' ' ASN . 2.2 m120 -74.61 -20.12 60.04 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 173.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.673 ' CB ' ' HB3' ' A' ' 16' ' ' CYS . 73.0 m-80 -135.41 73.64 62.58 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.678 -177.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -76.8 -43.26 0.27 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.827 2.351 . . . . 0.0 114.309 -173.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 -97.77 -17.02 19.61 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -173.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.489 HG12 ' HB3' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -99.38 -30.58 3.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.098 0.475 . . . . 0.0 110.966 179.492 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.673 ' HB3' ' CB ' ' A' ' 12' ' ' ASN . 43.5 t -130.63 -3.38 4.2 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.832 -170.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -110.18 -176.73 20.92 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.262 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.643 0 CA-C-N 117.648 0.724 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.666 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.527 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 2.9 p 39.75 53.13 2.54 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.65 0.78 . . . . 0.0 112.956 178.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 69.6 m -75.82 1.73 14.15 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.5 t -99.43 18.27 18.2 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.265 0.555 . . . . 0.0 109.61 174.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.2 m80 -131.3 123.24 19.51 Favored Pre-proline 0 C--N 1.334 -0.095 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.36 -174.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_exo -49.26 -42.51 40.01 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.305 2.67 . . . . 0.0 113.322 -178.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.64 -46.48 87.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.197 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.58 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 24.3 m -76.35 -11.99 59.99 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.29 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -83.78 -32.71 25.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.894 0.378 . . . . 0.0 110.172 177.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 51.2 t -84.86 -46.86 17.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.52 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.426 ' N ' HD21 ' A' ' 11' ' ' ASN . 2.4 m120 -69.04 -32.69 72.36 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.096 0.474 . . . . 0.0 110.364 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.58 ' HB2' ' O ' ' A' ' 8' ' ' CYS . 7.2 m120 -118.09 77.72 12.76 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.422 176.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -88.57 -33.65 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.23 1.954 . . . . 0.0 114.323 -170.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -98.41 -13.29 20.68 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.353 -175.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.486 HG12 ' HB3' ' A' ' 12' ' ' ASN . 0.1 OUTLIER -106.97 -32.1 2.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.195 0.521 . . . . 0.0 110.695 176.047 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.58 ' HB3' ' HB2' ' A' ' 12' ' ' ASN . 34.9 t -126.56 11.35 7.34 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.658 -169.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -135.67 -37.03 0.2 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.403 -0.904 . . . . 0.0 112.035 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.53 0 O-C-N 121.799 -0.824 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.897 0 N-CA-C 111.746 -0.542 . . . . 0.0 111.746 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.436 ' C ' ' H ' ' A' ' 4' ' ' SER . 7.6 t -81.79 -19.41 41.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 117.252 0.526 . . . . 0.0 109.678 177.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 80.2 m -77.63 17.5 0.53 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.994 175.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.436 ' H ' ' C ' ' A' ' 2' ' ' CYS . 7.0 m -104.8 6.52 34.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.249 176.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.421 ' NE2' ' HA ' ' A' ' 2' ' ' CYS . 0.9 OUTLIER -127.82 133.37 25.04 Favored Pre-proline 0 C--O 1.232 0.14 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 -176.046 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.4 ' O ' HG21 ' A' ' 10' ' ' VAL . 24.3 Cg_endo -61.64 -34.17 84.9 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.381 2.054 . . . . 0.0 112.036 177.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.85 -44.95 79.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.123 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 47.1 t -68.52 -27.33 66.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.574 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -71.68 -22.06 61.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.846 176.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 6' ' ' PRO . 93.7 t -73.47 -51.34 25.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.73 0.3 . . . . 0.0 110.346 176.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.458 HD21 ' N ' ' A' ' 11' ' ' ASN . 2.1 m120 -71.02 -31.86 68.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.201 0.524 . . . . 0.0 110.526 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.584 ' O ' ' HB3' ' A' ' 16' ' ' CYS . 74.4 m-80 -119.56 77.5 20.08 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.401 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -90.13 -36.74 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.73 2.287 . . . . 0.0 114.057 -174.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 32.5 p-80 -99.79 -17.63 17.58 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.848 0.356 . . . . 0.0 111.314 -176.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.38 -31.95 3.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.31 0.576 . . . . 0.0 111.127 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.584 ' HB3' ' O ' ' A' ' 12' ' ' ASN . 36.2 t -116.02 -74.58 0.6 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.835 -170.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -137.21 94.13 0.22 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.421 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.581 0 O-C-N 121.932 -0.746 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.884 0 N-CA-C 111.932 -0.467 . . . . 0.0 111.932 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.439 ' HA ' ' NE2' ' A' ' 5' ' ' HIS . 31.6 t -90.03 -13.75 35.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.003 0.43 . . . . 0.0 110.554 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 75.4 m -75.17 10.77 1.38 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.826 0.346 . . . . 0.0 111.486 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 37.2 m -99.9 8.19 44.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.071 177.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.439 ' NE2' ' HA ' ' A' ' 2' ' ' CYS . 1.2 m-70 -125.11 134.37 25.67 Favored Pre-proline 0 C--O 1.232 0.161 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 -175.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -52.43 -53.02 7.61 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.062 2.508 . . . . 0.0 113.497 -177.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.09 -38.05 87.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.661 -178.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.0 t -68.12 -28.55 67.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.872 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -75.07 -22.37 58.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.326 177.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 56.1 t -77.64 -56.47 7.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.854 0.359 . . . . 0.0 110.581 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -66.83 -24.87 66.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.88 0.372 . . . . 0.0 111.16 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.483 ' CB ' ' HB3' ' A' ' 16' ' ' CYS . 73.5 m-80 -122.88 78.62 49.82 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.12 178.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -96.3 -25.73 0.1 Allowed 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.663 2.242 . . . . 0.0 115.081 -170.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -98.46 -21.82 16.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.29 0.567 . . . . 0.0 111.093 -176.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.5 pt -105.22 -37.07 3.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.643 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.483 ' HB3' ' CB ' ' A' ' 12' ' ' ASN . 42.8 t -117.68 -12.18 10.31 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.746 -1.115 . . . . 0.0 111.05 -170.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -99.65 168.19 21.47 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.248 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.642 0 CA-C-N 117.738 0.769 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.845 0 N-CA-C 112.601 -0.2 . . . . 0.0 112.601 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.8 t -63.52 -26.05 68.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.895 0.378 . . . . 0.0 110.558 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 72.1 m -67.1 -2.95 6.25 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.2 t -98.63 22.84 9.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.999 0.428 . . . . 0.0 110.291 177.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -131.74 124.21 19.7 Favored Pre-proline 0 C--O 1.231 0.089 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.24 -176.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -55.41 -40.48 85.3 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.149 2.566 . . . . 0.0 113.54 -176.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.49 -34.39 70.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.846 0.355 . . . . 0.0 110.873 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 42.6 t -71.03 -24.4 62.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.173 0.511 . . . . 0.0 110.666 178.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -79.52 -12.3 59.87 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.136 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.7 t -77.42 -58.34 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.731 0.3 . . . . 0.0 110.369 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -76.04 -12.13 60.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.819 0.343 . . . . 0.0 111.152 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.623 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 82.3 m-20 -128.55 72.42 80.71 Favored Pre-proline 0 N--CA 1.465 0.285 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.133 174.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -83.16 -43.84 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.43 2.086 . . . . 0.0 114.913 -170.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -97.74 -19.0 18.49 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.909 0.385 . . . . 0.0 111.915 -171.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.9 pt -99.07 -32.35 3.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.041 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.623 ' HB3' ' HB3' ' A' ' 12' ' ' ASN . 22.3 t -127.67 -13.05 5.4 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.508 -169.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -99.82 -59.98 0.85 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.344 -0.931 . . . . 0.0 112.454 -177.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.532 0 O-C-N 121.907 -0.761 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.861 0 N-CA-C 111.809 -0.516 . . . . 0.0 111.809 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 13.1 t -116.25 -33.82 4.86 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 177.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 87.8 m -70.93 5.98 1.75 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 178.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.5 p -98.96 14.72 28.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.939 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 21.9 m80 -131.26 142.73 46.52 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.926 -176.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.46 ' O ' HG23 ' A' ' 10' ' ' VAL . 46.6 Cg_exo -57.71 -51.13 8.74 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.9 2.4 . . . . 0.0 113.21 -178.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.22 -45.69 92.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.744 -177.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.3 t -64.92 -28.23 69.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.877 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -73.39 -29.91 62.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.656 176.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 6' ' ' PRO . 64.4 t -73.58 -48.48 40.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.208 178.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -61.77 -42.18 98.66 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.598 178.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.543 ' CB ' ' HB3' ' A' ' 16' ' ' CYS . 4.9 m120 -115.01 78.7 5.65 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.002 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -64.59 -68.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.715 2.277 . . . . 0.0 113.857 -172.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -98.35 2.03 47.59 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.077 0.465 . . . . 0.0 111.31 -175.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.0 mp -99.15 -18.09 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.449 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.543 ' HB3' ' CB ' ' A' ' 12' ' ' ASN . 21.9 t -140.69 -36.09 0.47 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.598 -172.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -98.85 -137.16 9.66 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.532 -177.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.539 0 O-C-N 121.783 -0.833 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.908 0 N-CA-C 111.946 -0.462 . . . . 0.0 111.946 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.3 p -147.73 40.08 0.98 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.9 0.381 . . . . 0.0 110.416 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 44.5 m -67.77 5.15 0.91 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 p -98.85 15.31 25.9 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.97 0.414 . . . . 0.0 110.961 175.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.1 m80 -128.54 132.79 24.56 Favored Pre-proline 0 CA--C 1.519 -0.213 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.795 -175.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -51.52 -42.35 56.09 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.215 2.61 . . . . 0.0 113.388 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.571 ' O ' HG11 ' A' ' 10' ' ' VAL . . . -65.69 -42.88 90.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.85 0.357 . . . . 0.0 111.3 -179.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.53 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 79.4 m -69.61 -20.58 63.62 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.81 0.338 . . . . 0.0 110.938 178.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -85.57 -23.88 27.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.447 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.571 HG11 ' O ' ' A' ' 7' ' ' ALA . 6.2 p -84.64 -40.12 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.265 -176.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -80.21 -9.27 59.72 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.263 0.554 . . . . 0.0 110.166 175.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.583 ' CB ' ' HB3' ' A' ' 16' ' ' CYS . 68.4 m-80 -137.06 67.05 55.39 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.09 178.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -84.72 -30.5 0.57 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.285 1.99 . . . . 0.0 113.99 -172.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -99.35 -23.26 15.22 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.888 0.375 . . . . 0.0 111.582 -174.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.537 HG13 ' H ' ' A' ' 16' ' ' CYS . 5.2 pt -98.47 -46.77 12.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.481 0.657 . . . . 0.0 110.738 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.583 ' HB3' ' CB ' ' A' ' 12' ' ' ASN . 16.8 t -98.86 -27.53 13.87 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.985 -173.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -99.85 -9.23 49.83 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.912 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.478 0 O-C-N 121.698 -0.884 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.913 0 N-CA-C 112.276 -0.33 . . . . 0.0 112.276 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.8 p 40.36 55.91 2.73 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.795 0.838 . . . . 0.0 112.578 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.3 m -75.15 -4.5 39.11 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 45.3 m -98.74 18.71 16.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.931 0.395 . . . . 0.0 110.745 176.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.3 m80 -127.09 124.43 23.85 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.604 -174.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.48 ' O ' HG21 ' A' ' 10' ' ' VAL . 61.7 Cg_exo -54.05 -40.0 83.18 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.171 2.58 . . . . 0.0 113.383 -176.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.53 -43.23 97.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.866 0.365 . . . . 0.0 111.27 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.4 m -69.86 -25.01 63.52 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.056 0.455 . . . . 0.0 110.291 178.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -78.75 -13.13 59.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.013 178.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.48 HG21 ' O ' ' A' ' 6' ' ' PRO . 60.5 t -75.01 -52.75 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 175.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.455 ' N ' HD21 ' A' ' 11' ' ' ASN . 2.2 m120 -70.49 -31.71 68.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.559 178.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.5 ' CB ' ' HB3' ' A' ' 16' ' ' CYS . 74.7 m-80 -124.63 76.47 63.92 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.649 -178.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.642 ' HD2' HD13 ' A' ' 15' ' ' ILE . 36.6 Cg_endo -75.57 -59.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.64 2.227 . . . . 0.0 114.545 -172.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 24.5 p80 -98.46 -4.76 33.79 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.057 0.456 . . . . 0.0 111.172 -174.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.642 HD13 ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -98.61 -22.84 4.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.575 178.479 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.5 ' HB3' ' CB ' ' A' ' 12' ' ' ASN . 50.7 t -137.92 -17.31 1.24 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.863 -170.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -104.31 -130.31 6.81 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.147 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.529 0 CA-C-N 117.924 0.862 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.835 0 N-CA-C 111.788 -0.525 . . . . 0.0 111.788 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 7.9 p 39.26 50.94 2.02 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.562 0.745 . . . . 0.0 112.579 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 71.6 m -72.0 -2.06 16.85 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -177.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.8 p -98.86 21.11 11.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.042 0.449 . . . . 0.0 110.66 174.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.405 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 2.8 m80 -127.31 131.15 23.7 Favored Pre-proline 0 C--O 1.233 0.193 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.181 -175.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.538 ' O ' HG22 ' A' ' 10' ' ' VAL . 64.9 Cg_exo -53.2 -49.53 17.16 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.0 2.467 . . . . 0.0 113.026 -178.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.56 -39.13 86.84 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.061 -178.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.405 ' SG ' ' HB2' ' A' ' 5' ' ' HIS . 36.8 m -70.32 -29.01 65.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.87 0.367 . . . . 0.0 110.606 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -76.62 -20.18 57.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.291 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.538 HG22 ' O ' ' A' ' 6' ' ' PRO . 57.7 t -69.96 -51.8 36.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.929 0.395 . . . . 0.0 110.427 178.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -74.69 -32.02 62.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.149 0.5 . . . . 0.0 110.987 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.545 ' O ' ' HB3' ' A' ' 16' ' ' CYS . 74.4 m-80 -120.59 77.19 27.8 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.558 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -85.28 -42.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.1 2.533 . . . . 0.0 113.912 -172.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -98.05 -16.29 19.66 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.882 0.372 . . . . 0.0 111.362 -174.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.66 -27.66 3.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.006 178.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.545 ' HB3' ' O ' ' A' ' 12' ' ' ASN . 50.8 t -130.49 -6.69 4.19 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.079 -169.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -99.84 -53.48 1.11 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.166 -1.016 . . . . 0.0 112.262 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.589 0 O-C-N 121.846 -0.796 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.74 0 N-CA-C 112.102 -0.399 . . . . 0.0 112.102 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.6 p -133.62 45.87 2.62 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.915 0.388 . . . . 0.0 110.664 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 92.2 m -70.76 5.81 1.77 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 p -99.04 18.39 17.44 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.727 0.299 . . . . 0.0 110.66 174.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.5 m80 -130.75 136.29 28.7 Favored Pre-proline 0 C--O 1.234 0.238 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.546 -176.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -56.93 -40.93 80.54 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 123.035 2.49 . . . . 0.0 113.244 -178.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.584 ' O ' HG11 ' A' ' 10' ' ' VAL . . . -69.52 -37.21 77.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.206 -178.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.552 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 80.1 m -71.69 -22.3 61.67 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.793 0.33 . . . . 0.0 110.888 177.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -82.93 -25.2 32.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.93 179.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.584 HG11 ' O ' ' A' ' 7' ' ' ALA . 5.0 p -85.79 -39.62 13.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.361 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.417 HD21 ' N ' ' A' ' 11' ' ' ASN . 2.2 m120 -71.02 -16.49 62.62 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.053 0.454 . . . . 0.0 110.345 174.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.617 ' CB ' ' HB3' ' A' ' 16' ' ' CYS . 70.9 m-80 -137.7 77.63 38.7 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.298 -179.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -65.72 -66.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.167 2.578 . . . . 0.0 114.504 -172.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -97.48 -2.41 42.06 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.921 0.391 . . . . 0.0 111.486 -172.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.38 -25.82 3.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.893 178.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.617 ' HB3' ' CB ' ' A' ' 12' ' ' ASN . 36.9 t -136.52 -28.23 1.01 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.329 -169.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -105.16 13.27 48.67 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.275 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.513 0 O-C-N 121.972 -0.722 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.609 0 N-CA-C 111.933 -0.467 . . . . 0.0 111.933 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 23.6 p 41.83 45.86 3.25 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.675 0.79 . . . . 0.0 112.529 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 67.6 m -73.82 0.62 12.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.706 0.289 . . . . 0.0 111.601 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.2 p -98.71 17.31 19.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.525 175.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.1 m80 -127.64 131.96 24.09 Favored Pre-proline 0 N--CA 1.462 0.125 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.424 -175.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.47 ' O ' HG21 ' A' ' 10' ' ' VAL . 9.8 Cg_endo -57.83 -41.42 69.73 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.195 2.597 . . . . 0.0 113.444 -175.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.18 -42.22 93.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.077 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 58.9 m -66.45 -22.35 66.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.102 0.477 . . . . 0.0 110.648 177.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -85.43 -6.85 59.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.42 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.47 HG21 ' O ' ' A' ' 6' ' ' PRO . 48.4 t -82.12 -55.02 8.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 176.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -75.73 -20.78 58.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.178 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.54 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 71.9 m-20 -125.34 79.56 66.39 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.15 174.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -79.91 -56.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.021 2.481 . . . . 0.0 114.915 -170.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 23.2 p-80 -97.55 -10.11 25.83 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.575 -172.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -98.3 -31.73 3.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.259 0.552 . . . . 0.0 110.574 179.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.54 ' HB3' ' HB3' ' A' ' 12' ' ' ASN . 50.6 t -122.08 -19.07 6.73 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.085 -170.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -118.35 -18.07 5.07 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.167 178.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.533 0 O-C-N 121.908 -0.76 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.806 0 N-CA-C 111.921 -0.472 . . . . 0.0 111.921 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 4.4 p -119.9 49.95 1.33 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.844 0.354 . . . . 0.0 111.036 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.9 m -64.66 -2.42 2.43 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.1 p -99.59 20.44 13.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.808 0.337 . . . . 0.0 111.576 176.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 6.0 m80 -127.48 137.78 31.43 Favored Pre-proline 0 N--CA 1.462 0.166 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.225 -176.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -54.41 -48.57 20.77 Favored 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 123.033 2.488 . . . . 0.0 113.504 -176.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.547 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -67.92 -36.53 80.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.103 -178.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.597 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 62.5 m -68.75 -29.2 67.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.715 178.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -80.15 -30.95 38.97 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 7' ' ' ALA . 9.1 p -78.24 -37.72 22.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.949 -176.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -83.69 -1.17 53.49 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.896 0.379 . . . . 0.0 110.571 175.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.707 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 70.4 m-80 -141.13 71.4 27.89 Favored Pre-proline 0 N--CA 1.467 0.423 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.135 177.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -79.82 -44.57 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.767 2.311 . . . . 0.0 114.479 -170.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 30.2 p-80 -98.34 -15.09 19.87 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.803 0.335 . . . . 0.0 111.413 -174.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.455 HD13 HG21 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -99.3 -30.05 3.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.246 -179.147 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.707 ' HB3' ' HB3' ' A' ' 12' ' ' ASN . 33.7 t -130.06 -22.01 2.91 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.41 -169.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -99.31 178.02 30.12 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.26 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.562 0 CA-C-N 117.902 0.851 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.871 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.6 p -140.81 33.41 1.79 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.779 0.323 . . . . 0.0 110.903 178.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 85.4 m -70.63 -0.48 8.77 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -178.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.1 m -98.55 23.26 8.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.806 0.336 . . . . 0.0 110.737 175.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.0 m80 -132.48 129.4 21.44 Favored Pre-proline 0 C--O 1.233 0.2 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.38 -176.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.422 ' O ' HG21 ' A' ' 10' ' ' VAL . 86.7 Cg_exo -49.04 -43.08 37.31 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.307 2.671 . . . . 0.0 113.475 -177.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.46 -46.39 90.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.362 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.501 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 82.1 m -71.46 -15.72 62.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.749 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -85.19 -30.74 23.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.752 0.31 . . . . 0.0 110.666 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.422 HG21 ' O ' ' A' ' 6' ' ' PRO . 48.8 t -82.99 -48.69 17.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.243 177.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -65.48 -34.08 77.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.256 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.639 ' HB2' ' HB3' ' A' ' 16' ' ' CYS . 6.2 m120 -123.69 79.46 55.92 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.801 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -81.67 -42.88 0.1 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.351 2.034 . . . . 0.0 114.688 -170.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 27.2 p80 -98.56 -13.41 20.44 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.608 -173.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.491 HG12 ' HB3' ' A' ' 12' ' ' ASN . 0.1 OUTLIER -101.49 -32.83 3.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.72 176.716 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.639 ' HB3' ' HB2' ' A' ' 12' ' ' ASN . 20.0 t -127.12 2.67 6.46 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.675 -170.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -111.8 -46.98 0.75 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.237 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.504 0 O-C-N 121.822 -0.811 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.944 0 N-CA-C 112.05 -0.42 . . . . 0.0 112.05 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.7 t -123.58 -19.96 5.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.882 0.372 . . . . 0.0 110.263 178.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 95.3 m -72.32 6.06 2.51 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -177.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.8 p -98.87 18.97 15.83 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.788 175.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.9 m80 -129.99 131.55 23.55 Favored Pre-proline 0 C--O 1.232 0.176 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.229 -177.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.4 ' O ' HG21 ' A' ' 10' ' ' VAL . 77.3 Cg_exo -52.89 -52.93 7.71 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.097 2.531 . . . . 0.0 113.574 -176.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.78 -39.44 94.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.45 -178.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.8 t -64.79 -26.59 68.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.019 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -78.15 -22.96 47.96 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.273 177.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 6' ' ' PRO . 59.9 t -79.17 -48.88 20.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.884 0.373 . . . . 0.0 110.702 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -73.05 -27.76 61.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.987 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.547 ' CB ' ' HB3' ' A' ' 16' ' ' CYS . 76.9 m-20 -119.58 80.4 23.02 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.824 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -91.1 -38.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.891 2.394 . . . . 0.0 114.4 -172.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 56.1 p-80 -98.53 -12.45 21.22 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.762 -177.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.53 HG12 ' HB3' ' A' ' 12' ' ' ASN . 0.1 OUTLIER -101.84 -31.67 3.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.488 176.092 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.547 ' HB3' ' CB ' ' A' ' 12' ' ' ASN . 44.9 t -131.73 17.25 4.75 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.553 -170.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -99.08 -113.76 3.43 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.167 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.569 0 O-C-N 121.72 -0.871 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.825 0 N-CA-C 111.926 -0.469 . . . . 0.0 111.926 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.432 ' O ' ' HB3' ' A' ' 8' ' ' CYS . 2.0 p -139.7 30.38 2.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.841 0.353 . . . . 0.0 111.382 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 94.2 m -69.6 -4.04 17.55 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.1 m -99.79 12.06 37.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.563 0.221 . . . . 0.0 111.048 176.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.4 m80 -124.4 127.48 25.26 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.795 -174.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -55.04 -38.07 93.58 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.271 2.647 . . . . 0.0 113.925 -175.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.668 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -67.9 -43.04 80.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.099 0.476 . . . . 0.0 110.777 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.657 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 52.6 t -70.28 -19.58 63.09 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.621 178.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -83.24 -17.8 41.41 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.668 HG12 ' O ' ' A' ' 7' ' ' ALA . 4.8 p -84.04 -41.18 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.116 -176.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -88.83 -5.79 57.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.006 0.432 . . . . 0.0 110.126 175.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.691 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 74.7 m-20 -135.61 71.45 65.15 Favored Pre-proline 0 N--CA 1.465 0.292 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.199 174.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -85.69 -42.43 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.901 2.401 . . . . 0.0 114.088 -172.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 -98.21 -15.95 19.66 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.044 0.449 . . . . 0.0 111.079 -176.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.17 -30.58 3.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.894 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.691 ' HB3' ' HB3' ' A' ' 12' ' ' ASN . 35.4 t -134.63 4.14 3.33 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.479 -170.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -99.25 15.52 60.2 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.397 -0.906 . . . . 0.0 111.95 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.557 0 O-C-N 121.978 -0.719 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 87.2 m . . . . . 0 N--CA 1.468 0.438 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.5 p -99.06 24.47 7.79 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.703 0.287 . . . . 0.0 111.739 177.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -134.88 129.4 19.17 Favored Pre-proline 0 C--O 1.232 0.174 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.354 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.425 ' O ' HG23 ' A' ' 10' ' ' VAL . 9.2 Cg_endo -54.88 -37.1 93.03 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.104 2.536 . . . . 0.0 113.124 -178.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.57 -36.62 70.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.882 0.372 . . . . 0.0 111.18 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.7 t -72.93 -19.2 61.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.601 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -82.55 -11.31 58.54 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.081 176.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 6' ' ' PRO . 55.1 t -79.47 -53.08 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.716 0.293 . . . . 0.0 110.459 177.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.427 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 1.9 p-10 -74.09 -26.71 60.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.05 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.708 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 23.0 m120 -119.68 78.93 22.41 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.738 174.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 11' ' ' ASN . 10.1 Cg_exo -77.9 -59.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.924 2.416 . . . . 0.0 114.475 -170.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -97.92 -6.62 31.88 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.508 -172.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.582 HD13 ' H ' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -99.37 -30.72 3.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.857 176.858 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.708 ' HB3' ' HB3' ' A' ' 12' ' ' ASN . 52.4 t -127.35 -15.83 5.06 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.173 -170.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.357 -0.925 . . . . 0.0 111.819 177.757 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 97.0 m . . . . . 0 N--CA 1.462 0.172 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.4 p -99.65 16.66 22.75 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.143 0.497 . . . . 0.0 110.408 173.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -125.77 130.55 24.01 Favored Pre-proline 0 C--O 1.233 0.227 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.049 -175.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.444 ' O ' HG23 ' A' ' 10' ' ' VAL . 6.5 Cg_endo -52.34 -46.27 34.02 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.325 2.684 . . . . 0.0 113.518 -175.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.98 -44.97 94.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.838 0.351 . . . . 0.0 111.456 -178.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.49 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 11.9 m -71.9 -15.78 62.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.243 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -85.51 -25.69 26.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.664 0.268 . . . . 0.0 111.002 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 6' ' ' PRO . 62.0 t -82.08 -52.44 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.367 178.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.8 m-20 -67.43 -31.18 71.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.564 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.656 ' HB2' ' HB3' ' A' ' 16' ' ' CYS . 5.1 m120 -119.4 77.29 18.6 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 177.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -83.57 -42.19 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.375 2.05 . . . . 0.0 115.088 -168.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 34.1 p-80 -98.38 -16.36 19.33 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.223 0.535 . . . . 0.0 110.96 -175.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.539 HD13 ' H ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -98.3 -28.71 3.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.079 -179.461 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.656 ' HB3' ' HB2' ' A' ' 12' ' ' ASN . 42.6 t -130.36 -26.9 2.26 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.379 -169.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.391 0 C-N-CA 120.249 -0.977 . . . . 0.0 112.339 -178.244 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 55.8 m . . . . . 0 N--CA 1.464 0.225 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.1 m -98.74 17.04 20.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.131 0.491 . . . . 0.0 110.36 175.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -128.33 128.58 23.65 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.021 -175.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.515 ' O ' HG23 ' A' ' 10' ' ' VAL . 52.4 Cg_exo -56.06 -42.31 67.85 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.878 2.385 . . . . 0.0 113.166 -176.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.04 -42.86 99.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.971 0.415 . . . . 0.0 111.328 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 66.1 m -68.93 -25.13 64.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.899 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -77.93 -29.95 50.23 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.619 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 6' ' ' PRO . 85.7 t -68.03 -50.14 61.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.113 0.483 . . . . 0.0 109.878 175.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -68.25 -30.08 69.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.111 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.556 ' O ' ' HB3' ' A' ' 16' ' ' CYS . 69.2 m-80 -125.6 78.42 68.6 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.719 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -89.2 -26.47 0.46 Allowed 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 122.49 2.127 . . . . 0.0 114.31 -173.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.446 ' ND1' HG23 ' A' ' 15' ' ' ILE . 18.1 p80 -100.01 -26.61 13.92 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.882 0.372 . . . . 0.0 111.95 -173.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.446 HG23 ' ND1' ' A' ' 14' ' ' HIS . 4.1 pt -99.46 -34.39 4.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.257 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.556 ' HB3' ' O ' ' A' ' 12' ' ' ASN . 40.6 t -111.34 -64.19 1.31 Allowed 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.938 -1.028 . . . . 0.0 112.154 -166.266 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.421 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.662 -177.995 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 86.3 m . . . . . 0 N--CA 1.464 0.237 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.6 t -98.93 15.12 26.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.987 0.422 . . . . 0.0 110.101 175.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -129.61 132.53 24.27 Favored Pre-proline 0 CA--C 1.518 -0.258 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.544 -175.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.588 ' O ' HG23 ' A' ' 10' ' ' VAL . 51.7 Cg_exo -55.6 -47.11 27.24 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.927 2.418 . . . . 0.0 112.996 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.51 -40.02 95.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.855 0.359 . . . . 0.0 111.398 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.6 t -69.61 -27.17 64.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.736 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -77.37 -23.86 50.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.87 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 6' ' ' PRO . 72.2 t -77.3 -50.93 19.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.778 0.323 . . . . 0.0 110.23 177.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.8 m-20 -69.24 -27.73 65.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.75 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.545 ' CB ' ' HB3' ' A' ' 16' ' ' CYS . 74.6 m-20 -122.21 77.14 42.92 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.482 177.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -87.49 -38.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.185 1.923 . . . . 0.0 114.978 -168.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -98.77 -9.21 24.77 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.376 0.608 . . . . 0.0 111.276 -174.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.9 pt -108.45 -41.02 4.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.583 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.545 ' HB3' ' CB ' ' A' ' 12' ' ' ASN . 44.7 t -115.04 -26.99 7.5 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.583 -170.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.419 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.378 -179.156 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 84.8 m . . . . . 0 N--CA 1.458 -0.067 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 54.9 m -98.51 23.79 8.15 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.123 0.487 . . . . 0.0 110.574 174.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.455 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . 9.6 m80 -130.37 118.21 18.06 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.829 -176.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 5' ' ' HIS . 3.8 Cg_endo -51.01 -47.05 27.46 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.441 2.761 . . . . 0.0 113.631 -174.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.02 -41.43 95.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.798 0.333 . . . . 0.0 111.215 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.8 t -66.82 -26.38 66.9 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.167 178.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -72.83 -15.11 61.63 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.672 0.272 . . . . 0.0 111.122 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.422 ' O ' ' HG3' ' A' ' 13' ' ' PRO . 59.6 t -83.28 -49.05 17.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.621 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.425 ' C ' ' HD3' ' A' ' 13' ' ' PRO . 2.0 p-10 -78.75 -21.54 47.81 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.816 0.341 . . . . 0.0 110.86 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.678 ' HB3' ' CB ' ' A' ' 16' ' ' CYS . 37.4 m-20 -122.23 74.81 40.83 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.156 174.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.425 ' HD3' ' C ' ' A' ' 11' ' ' ASN . 10.3 Cg_exo -77.55 -58.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.028 2.486 . . . . 0.0 113.946 -172.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 49.6 p-80 -98.38 -12.45 21.42 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.481 -175.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.573 HD12 ' H ' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -97.97 -2.74 9.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.914 0.388 . . . . 0.0 110.27 -179.194 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.678 ' CB ' ' HB3' ' A' ' 12' ' ' ASN . 52.5 t -143.83 -67.98 0.34 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.079 -175.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 C-N-CA 120.005 -1.093 . . . . 0.0 112.663 -175.756 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 67.9 m . . . . . 0 N--CA 1.467 0.376 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.0 t -99.17 5.71 46.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.055 0.455 . . . . 0.0 110.226 175.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 8.0 m80 -121.62 132.82 24.15 Favored Pre-proline 0 C--O 1.232 0.134 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.715 -174.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 5' ' ' HIS . 54.0 Cg_exo -54.8 -39.63 88.86 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.176 2.584 . . . . 0.0 113.501 -177.092 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.496 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -65.73 -39.5 91.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.887 0.375 . . . . 0.0 111.262 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.509 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 46.9 m -73.2 -23.11 60.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.532 178.084 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -85.12 -22.85 28.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.292 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.496 HG12 ' O ' ' A' ' 7' ' ' ALA . 6.2 p -85.67 -36.11 10.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.723 0.297 . . . . 0.0 110.451 -178.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 -74.61 -20.12 60.04 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 173.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.674 ' CB ' ' HB3' ' A' ' 16' ' ' CYS . 73.0 m-80 -135.41 73.64 62.58 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.678 -177.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -76.8 -43.26 0.27 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.827 2.351 . . . . 0.0 114.309 -173.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 -97.77 -17.02 19.61 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -173.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.504 HG12 ' HB3' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -99.38 -30.58 3.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.098 0.475 . . . . 0.0 110.966 179.492 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.674 ' HB3' ' CB ' ' A' ' 12' ' ' ASN . 43.5 t -130.63 -3.38 4.2 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.832 -170.015 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.429 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.262 178.77 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 69.6 m . . . . . 0 CA--C 1.528 0.11 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.5 t -99.43 18.27 18.2 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.265 0.555 . . . . 0.0 109.61 174.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.2 m80 -131.3 123.24 19.51 Favored Pre-proline 0 C--N 1.334 -0.095 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.36 -174.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.423 ' O ' HG23 ' A' ' 10' ' ' VAL . 79.5 Cg_exo -49.26 -42.51 40.01 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.305 2.67 . . . . 0.0 113.322 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.64 -46.48 87.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.197 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.58 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 24.3 m -76.35 -11.99 59.99 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.29 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -83.78 -32.71 25.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.894 0.378 . . . . 0.0 110.172 177.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 6' ' ' PRO . 51.2 t -84.86 -46.86 17.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.52 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.4 m-20 -69.04 -32.69 72.36 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.096 0.474 . . . . 0.0 110.364 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.608 ' HB2' ' HB3' ' A' ' 16' ' ' CYS . 7.2 m120 -118.09 77.72 12.76 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.422 176.064 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -88.57 -33.65 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.23 1.954 . . . . 0.0 114.323 -170.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -98.41 -13.29 20.68 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.353 -175.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.623 HD13 ' H ' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -106.97 -32.1 2.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.195 0.521 . . . . 0.0 110.695 176.047 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.608 ' HB3' ' HB2' ' A' ' 12' ' ' ASN . 34.9 t -126.56 11.35 7.34 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.658 -169.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.396 0 C-N-CA 120.403 -0.904 . . . . 0.0 112.035 179.384 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 80.2 m . . . . . 0 N--CA 1.455 -0.185 0 CA-C-O 120.823 0.344 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.0 m -104.8 6.52 34.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.249 176.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -127.82 133.37 25.04 Favored Pre-proline 0 C--O 1.232 0.14 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 -176.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.543 ' O ' HG23 ' A' ' 10' ' ' VAL . 24.3 Cg_endo -61.64 -34.17 84.9 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.381 2.054 . . . . 0.0 112.036 177.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.85 -44.95 79.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.123 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 47.1 t -68.52 -27.33 66.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.574 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -71.68 -22.06 61.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.846 176.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 6' ' ' PRO . 93.7 t -73.47 -51.34 25.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.73 0.3 . . . . 0.0 110.346 176.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.8 m-20 -71.02 -31.86 68.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.201 0.524 . . . . 0.0 110.526 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.583 ' O ' ' HB3' ' A' ' 16' ' ' CYS . 74.4 m-80 -119.56 77.5 20.08 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.401 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -90.13 -36.74 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.73 2.287 . . . . 0.0 114.057 -174.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 32.5 p-80 -99.79 -17.63 17.58 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.848 0.356 . . . . 0.0 111.314 -176.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.524 HD13 ' H ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -99.38 -31.95 3.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.31 0.576 . . . . 0.0 111.127 -179.307 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.583 ' HB3' ' O ' ' A' ' 12' ' ' ASN . 36.2 t -116.02 -74.58 0.6 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.835 -170.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.422 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.421 -179.063 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 75.4 m . . . . . 0 CA--C 1.524 -0.048 0 CA-C-O 120.826 0.346 . . . . 0.0 111.486 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 37.2 m -99.9 8.19 44.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.071 177.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -125.11 134.37 25.67 Favored Pre-proline 0 C--O 1.232 0.161 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 -175.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.446 ' O ' HG23 ' A' ' 10' ' ' VAL . 70.4 Cg_exo -52.43 -53.02 7.61 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.062 2.508 . . . . 0.0 113.497 -177.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.09 -38.05 87.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.661 -178.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.0 t -68.12 -28.55 67.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.872 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -75.07 -22.37 58.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.326 177.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 6' ' ' PRO . 56.1 t -77.64 -56.47 7.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.854 0.359 . . . . 0.0 110.581 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -66.83 -24.87 66.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.88 0.372 . . . . 0.0 111.16 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.487 ' CB ' ' HB3' ' A' ' 16' ' ' CYS . 73.5 m-80 -122.88 78.62 49.82 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.12 178.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -96.3 -25.73 0.1 Allowed 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.663 2.242 . . . . 0.0 115.081 -170.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -98.46 -21.82 16.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.29 0.567 . . . . 0.0 111.093 -176.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.5 pt -105.22 -37.07 3.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.643 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.487 ' HB3' ' CB ' ' A' ' 12' ' ' ASN . 42.8 t -117.68 -12.18 10.31 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.746 -1.115 . . . . 0.0 111.05 -170.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.248 -179.189 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 72.1 m . . . . . 0 N--CA 1.463 0.21 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.2 t -98.63 22.84 9.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.999 0.428 . . . . 0.0 110.291 177.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.405 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . 15.4 m80 -131.74 124.21 19.7 Favored Pre-proline 0 C--O 1.231 0.089 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.24 -176.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 5' ' ' HIS . 10.0 Cg_endo -55.41 -40.48 85.3 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.149 2.566 . . . . 0.0 113.54 -176.127 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.49 -34.39 70.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.846 0.355 . . . . 0.0 110.873 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 42.6 t -71.03 -24.4 62.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.173 0.511 . . . . 0.0 110.666 178.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -79.52 -12.3 59.87 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.136 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.7 t -77.42 -58.34 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.731 0.3 . . . . 0.0 110.369 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -76.04 -12.13 60.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.819 0.343 . . . . 0.0 111.152 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.656 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 82.3 m-20 -128.55 72.42 80.71 Favored Pre-proline 0 N--CA 1.465 0.285 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.133 174.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -83.16 -43.84 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.43 2.086 . . . . 0.0 114.913 -170.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -97.74 -19.0 18.49 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.909 0.385 . . . . 0.0 111.915 -171.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.9 pt -99.07 -32.35 3.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.041 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.656 ' HB3' ' HB3' ' A' ' 12' ' ' ASN . 22.3 t -127.67 -13.05 5.4 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.508 -169.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 C-N-CA 120.344 -0.931 . . . . 0.0 112.454 -177.632 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 87.8 m . . . . . 0 N--CA 1.462 0.148 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.5 p -98.96 14.72 28.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.939 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.428 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 21.9 m80 -131.26 142.73 46.52 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.926 -176.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.518 ' O ' HG23 ' A' ' 10' ' ' VAL . 46.6 Cg_exo -57.71 -51.13 8.74 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.9 2.4 . . . . 0.0 113.21 -178.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.22 -45.69 92.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.744 -177.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.3 t -64.92 -28.23 69.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.877 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -73.39 -29.91 62.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.656 176.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 6' ' ' PRO . 64.4 t -73.58 -48.48 40.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.208 178.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 -61.77 -42.18 98.66 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.598 178.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.546 ' CB ' ' HB3' ' A' ' 16' ' ' CYS . 64.5 m-20 -115.01 78.7 5.65 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.002 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -64.59 -68.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.715 2.277 . . . . 0.0 113.857 -172.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -98.35 2.03 47.59 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.077 0.465 . . . . 0.0 111.31 -175.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.434 HD12 ' H ' ' A' ' 15' ' ' ILE . 3.0 mp -99.15 -18.09 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.449 177.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.546 ' HB3' ' CB ' ' A' ' 12' ' ' ASN . 21.9 t -140.69 -36.09 0.47 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.598 -172.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.204 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.532 -177.623 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 44.5 m . . . . . 0 N--CA 1.468 0.449 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 p -98.85 15.31 25.9 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.97 0.414 . . . . 0.0 110.961 175.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.1 m80 -128.54 132.79 24.56 Favored Pre-proline 0 CA--C 1.519 -0.213 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.795 -175.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -51.52 -42.35 56.09 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.215 2.61 . . . . 0.0 113.388 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.526 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -65.69 -42.88 90.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.85 0.357 . . . . 0.0 111.3 -179.275 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.526 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 79.4 m -69.61 -20.58 63.62 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.81 0.338 . . . . 0.0 110.938 178.305 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -85.57 -23.88 27.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.447 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 7' ' ' ALA . 6.2 p -84.64 -40.12 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.265 -176.322 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -80.21 -9.27 59.72 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.263 0.554 . . . . 0.0 110.166 175.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.59 ' CB ' ' HB3' ' A' ' 16' ' ' CYS . 68.4 m-80 -137.06 67.05 55.39 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.09 178.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -84.72 -30.5 0.57 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.285 1.99 . . . . 0.0 113.99 -172.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -99.35 -23.26 15.22 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.888 0.375 . . . . 0.0 111.582 -174.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.473 HG13 ' H ' ' A' ' 16' ' ' CYS . 5.2 pt -98.47 -46.77 12.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.481 0.657 . . . . 0.0 110.738 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.59 ' HB3' ' CB ' ' A' ' 12' ' ' ASN . 16.8 t -98.86 -27.53 13.87 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.985 -173.288 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.399 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.912 177.599 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.3 m . . . . . 0 N--CA 1.461 0.082 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 45.3 m -98.74 18.71 16.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.931 0.395 . . . . 0.0 110.745 176.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.3 m80 -127.09 124.43 23.85 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.604 -174.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.504 ' O ' HG23 ' A' ' 10' ' ' VAL . 61.7 Cg_exo -54.05 -40.0 83.18 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.171 2.58 . . . . 0.0 113.383 -176.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.53 -43.23 97.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.866 0.365 . . . . 0.0 111.27 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.4 m -69.86 -25.01 63.52 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.056 0.455 . . . . 0.0 110.291 178.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -78.75 -13.13 59.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.013 178.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 6' ' ' PRO . 60.5 t -75.01 -52.75 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 175.062 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.0 m-20 -70.49 -31.71 68.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.559 178.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.531 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 74.7 m-80 -124.63 76.47 63.92 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.649 -178.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.491 ' HD2' HD11 ' A' ' 15' ' ' ILE . 36.6 Cg_endo -75.57 -59.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.64 2.227 . . . . 0.0 114.545 -172.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 24.5 p80 -98.46 -4.76 33.79 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.057 0.456 . . . . 0.0 111.172 -174.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.491 HD11 ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -98.61 -22.84 4.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.575 178.479 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.531 ' HB3' ' HB3' ' A' ' 12' ' ' ASN . 50.7 t -137.92 -17.31 1.24 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.863 -170.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.147 178.03 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 71.6 m . . . . . 0 N--CA 1.462 0.163 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.8 p -98.86 21.11 11.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.042 0.449 . . . . 0.0 110.66 174.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.421 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 2.8 m80 -127.31 131.15 23.7 Favored Pre-proline 0 C--O 1.233 0.193 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.181 -175.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.55 ' O ' HG23 ' A' ' 10' ' ' VAL . 64.9 Cg_exo -53.2 -49.53 17.16 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.0 2.467 . . . . 0.0 113.026 -178.08 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.56 -39.13 86.84 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.061 -178.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.421 ' SG ' ' HB2' ' A' ' 5' ' ' HIS . 36.8 m -70.32 -29.01 65.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.87 0.367 . . . . 0.0 110.606 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 61.7 m-20 -76.62 -20.18 57.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.291 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 6' ' ' PRO . 57.7 t -69.96 -51.8 36.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.929 0.395 . . . . 0.0 110.427 178.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.408 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 62.1 m-80 -74.69 -32.02 62.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.149 0.5 . . . . 0.0 110.987 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.544 ' O ' ' HB3' ' A' ' 16' ' ' CYS . 74.4 m-80 -120.59 77.19 27.8 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.558 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 11' ' ' ASN . 6.1 Cg_exo -85.28 -42.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.1 2.533 . . . . 0.0 113.912 -172.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -98.05 -16.29 19.66 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.882 0.372 . . . . 0.0 111.362 -174.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.488 HD13 ' H ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -98.66 -27.66 3.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.006 178.349 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.544 ' HB3' ' O ' ' A' ' 12' ' ' ASN . 50.8 t -130.49 -6.69 4.19 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.079 -169.498 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 C-N-CA 120.166 -1.016 . . . . 0.0 112.262 179.109 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 92.2 m . . . . . 0 N--CA 1.463 0.187 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 p -99.04 18.39 17.44 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.727 0.299 . . . . 0.0 110.66 174.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 14.5 m80 -130.75 136.29 28.7 Favored Pre-proline 0 C--O 1.234 0.238 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.546 -176.036 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 5' ' ' HIS . 49.2 Cg_exo -56.93 -40.93 80.54 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 123.035 2.49 . . . . 0.0 113.244 -178.038 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.502 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -69.52 -37.21 77.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.206 -178.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.551 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 80.1 m -71.69 -22.3 61.67 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.793 0.33 . . . . 0.0 110.888 177.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -82.93 -25.2 32.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.93 179.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.502 HG12 ' O ' ' A' ' 7' ' ' ALA . 5.0 p -85.79 -39.62 13.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.361 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 25.6 m-20 -71.02 -16.49 62.62 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.053 0.454 . . . . 0.0 110.345 174.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.619 ' CB ' ' HB3' ' A' ' 16' ' ' CYS . 70.9 m-80 -137.7 77.63 38.7 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.298 -179.211 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -65.72 -66.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.167 2.578 . . . . 0.0 114.504 -172.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -97.48 -2.41 42.06 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.921 0.391 . . . . 0.0 111.486 -172.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.4 HD13 ' H ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -99.38 -25.82 3.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.893 178.858 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.619 ' HB3' ' CB ' ' A' ' 12' ' ' ASN . 36.9 t -136.52 -28.23 1.01 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.329 -169.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.275 -179.377 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 67.6 m . . . . . 0 N--CA 1.463 0.181 0 CA-C-O 120.706 0.289 . . . . 0.0 111.601 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.2 p -98.71 17.31 19.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.525 175.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.1 m80 -127.64 131.96 24.09 Favored Pre-proline 0 N--CA 1.462 0.125 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.424 -175.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.454 ' O ' HG23 ' A' ' 10' ' ' VAL . 9.8 Cg_endo -57.83 -41.42 69.73 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.195 2.597 . . . . 0.0 113.444 -175.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.18 -42.22 93.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.077 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 58.9 m -66.45 -22.35 66.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.102 0.477 . . . . 0.0 110.648 177.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -85.43 -6.85 59.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.42 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 6' ' ' PRO . 48.4 t -82.12 -55.02 8.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 176.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -75.73 -20.78 58.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.178 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.573 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 71.9 m-20 -125.34 79.56 66.39 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.15 174.256 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -79.91 -56.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.021 2.481 . . . . 0.0 114.915 -170.024 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 23.2 p-80 -97.55 -10.11 25.83 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.575 -172.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.593 HD13 ' H ' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -98.3 -31.73 3.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.259 0.552 . . . . 0.0 110.574 179.06 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.573 ' HB3' ' HB3' ' A' ' 12' ' ' ASN . 50.6 t -122.08 -19.07 6.73 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.085 -170.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.399 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.167 178.108 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.9 m . . . . . 0 N--CA 1.467 0.383 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.1 p -99.59 20.44 13.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.808 0.337 . . . . 0.0 111.576 176.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 6.0 m80 -127.48 137.78 31.43 Favored Pre-proline 0 N--CA 1.462 0.166 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.225 -176.22 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 5' ' ' HIS . 58.2 Cg_exo -54.41 -48.57 20.77 Favored 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 123.033 2.488 . . . . 0.0 113.504 -176.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.426 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -67.92 -36.53 80.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.103 -178.161 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.599 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 62.5 m -68.75 -29.2 67.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.715 178.437 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -80.15 -30.95 38.97 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.426 HG12 ' O ' ' A' ' 7' ' ' ALA . 9.1 p -78.24 -37.72 22.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.949 -176.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -83.69 -1.17 53.49 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.896 0.379 . . . . 0.0 110.571 175.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.74 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 70.4 m-80 -141.13 71.4 27.89 Favored Pre-proline 0 N--CA 1.467 0.423 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.135 177.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -79.82 -44.57 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.767 2.311 . . . . 0.0 114.479 -170.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 30.2 p-80 -98.34 -15.09 19.87 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.803 0.335 . . . . 0.0 111.413 -174.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.516 HD13 ' H ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -99.3 -30.05 3.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.246 -179.147 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.74 ' HB3' ' HB3' ' A' ' 12' ' ' ASN . 33.7 t -130.06 -22.01 2.91 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.41 -169.072 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.26 -179.214 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 85.4 m . . . . . 0 N--CA 1.464 0.25 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.1 m -98.55 23.26 8.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.806 0.336 . . . . 0.0 110.737 175.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.0 m80 -132.48 129.4 21.44 Favored Pre-proline 0 C--O 1.233 0.2 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.38 -176.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.422 ' O ' HG23 ' A' ' 10' ' ' VAL . 86.7 Cg_exo -49.04 -43.08 37.31 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.307 2.671 . . . . 0.0 113.475 -177.259 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.46 -46.39 90.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.362 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.497 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 82.1 m -71.46 -15.72 62.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.749 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -85.19 -30.74 23.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.752 0.31 . . . . 0.0 110.666 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 6' ' ' PRO . 48.8 t -82.99 -48.69 17.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.243 177.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 31.4 m-20 -65.48 -34.08 77.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.256 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.669 ' HB2' ' HB3' ' A' ' 16' ' ' CYS . 6.2 m120 -123.69 79.46 55.92 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.801 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -81.67 -42.88 0.1 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.351 2.034 . . . . 0.0 114.688 -170.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 27.2 p80 -98.56 -13.41 20.44 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.608 -173.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.586 HD13 ' H ' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -101.49 -32.83 3.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.72 176.716 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.669 ' HB3' ' HB2' ' A' ' 12' ' ' ASN . 20.0 t -127.12 2.67 6.46 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.675 -170.097 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.466 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.237 -179.462 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 95.3 m . . . . . 0 N--CA 1.464 0.247 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.8 p -98.87 18.97 15.83 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.788 175.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.9 m80 -129.99 131.55 23.55 Favored Pre-proline 0 C--O 1.232 0.176 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.229 -177.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.432 ' O ' HG23 ' A' ' 10' ' ' VAL . 77.3 Cg_exo -52.89 -52.93 7.71 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.097 2.531 . . . . 0.0 113.574 -176.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.78 -39.44 94.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.45 -178.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.8 t -64.79 -26.59 68.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.019 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -78.15 -22.96 47.96 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.273 177.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 6' ' ' PRO . 59.9 t -79.17 -48.88 20.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.884 0.373 . . . . 0.0 110.702 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.408 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 62.3 m-80 -73.05 -27.76 61.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.987 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.551 ' CB ' ' HB3' ' A' ' 16' ' ' CYS . 76.9 m-20 -119.58 80.4 23.02 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.824 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 11' ' ' ASN . 1.0 OUTLIER -91.1 -38.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.891 2.394 . . . . 0.0 114.4 -172.486 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 56.1 p-80 -98.53 -12.45 21.22 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.762 -177.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.565 HD13 ' H ' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -101.84 -31.67 3.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.488 176.092 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.551 ' HB3' ' CB ' ' A' ' 12' ' ' ASN . 44.9 t -131.73 17.25 4.75 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.553 -170.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.235 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.167 178.314 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 94.2 m . . . . . 0 N--CA 1.463 0.19 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.1 m -99.79 12.06 37.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.563 0.221 . . . . 0.0 111.048 176.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 8.4 m80 -124.4 127.48 25.26 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.795 -174.211 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 5' ' ' HIS . 69.4 Cg_exo -55.04 -38.07 93.58 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.271 2.647 . . . . 0.0 113.925 -175.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.676 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -67.9 -43.04 80.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.099 0.476 . . . . 0.0 110.777 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.663 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 52.6 t -70.28 -19.58 63.09 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.621 178.41 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 63.3 m-20 -83.24 -17.8 41.41 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.676 HG12 ' O ' ' A' ' 7' ' ' ALA . 4.8 p -84.04 -41.18 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.116 -176.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -88.83 -5.79 57.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.006 0.432 . . . . 0.0 110.126 175.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.729 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 74.7 m-20 -135.61 71.45 65.15 Favored Pre-proline 0 N--CA 1.465 0.292 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.199 174.39 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -85.69 -42.43 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.901 2.401 . . . . 0.0 114.088 -172.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 -98.21 -15.95 19.66 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.044 0.449 . . . . 0.0 111.079 -176.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.511 HD13 ' H ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -99.17 -30.58 3.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.894 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.729 ' HB3' ' HB3' ' A' ' 12' ' ' ASN . 35.4 t -134.63 4.14 3.33 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.479 -170.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.48 0 C-N-CA 120.397 -0.906 . . . . 0.0 111.95 179.151 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.887 0 N-CA-C 111.658 -0.577 . . . . 0.0 111.658 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 11.2 t -102.95 -32.16 9.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 117.064 0.432 . . . . 0.0 110.503 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 87.2 m -64.58 -2.66 2.51 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.5 p -99.06 24.47 7.79 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.703 0.287 . . . . 0.0 111.739 177.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -134.88 129.4 19.17 Favored Pre-proline 0 C--O 1.232 0.174 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.354 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.425 ' O ' HG23 ' A' ' 10' ' ' VAL . 9.2 Cg_endo -54.88 -37.1 93.03 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.104 2.536 . . . . 0.0 113.124 -178.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.57 -36.62 70.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.882 0.372 . . . . 0.0 111.18 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.7 t -72.93 -19.2 61.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.601 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -82.55 -11.31 58.54 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.081 176.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 6' ' ' PRO . 55.1 t -79.47 -53.08 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.716 0.293 . . . . 0.0 110.459 177.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.427 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 1.9 p-10 -74.09 -26.71 60.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.05 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.708 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 23.0 m120 -119.68 78.93 22.41 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.738 174.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 11' ' ' ASN . 10.1 Cg_exo -77.9 -59.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.924 2.416 . . . . 0.0 114.475 -170.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -97.92 -6.62 31.88 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.508 -172.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.582 HD13 ' H ' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -99.37 -30.72 3.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.857 176.858 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.708 ' HB3' ' HB3' ' A' ' 12' ' ' ASN . 52.4 t -127.35 -15.83 5.06 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.173 -170.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.33 -27.68 3.3 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.357 -0.925 . . . . 0.0 111.819 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.554 0 O-C-N 121.913 -0.757 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.929 0 N-CA-C 111.961 -0.455 . . . . 0.0 111.961 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 4.8 p 40.13 51.87 2.69 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.395 0.678 . . . . 0.0 112.382 178.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 97.0 m -75.99 0.15 19.53 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -177.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.4 p -99.65 16.66 22.75 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.143 0.497 . . . . 0.0 110.408 173.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -125.77 130.55 24.01 Favored Pre-proline 0 C--O 1.233 0.227 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.049 -175.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.444 ' O ' HG23 ' A' ' 10' ' ' VAL . 6.5 Cg_endo -52.34 -46.27 34.02 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.325 2.684 . . . . 0.0 113.518 -175.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.98 -44.97 94.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.838 0.351 . . . . 0.0 111.456 -178.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.49 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 11.9 m -71.9 -15.78 62.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.243 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -85.51 -25.69 26.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.664 0.268 . . . . 0.0 111.002 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 6' ' ' PRO . 62.0 t -82.08 -52.44 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.367 178.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.8 m-20 -67.43 -31.18 71.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.564 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.656 ' HB2' ' HB3' ' A' ' 16' ' ' CYS . 5.1 m120 -119.4 77.29 18.6 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 177.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -83.57 -42.19 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.375 2.05 . . . . 0.0 115.088 -168.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 34.1 p-80 -98.38 -16.36 19.33 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.223 0.535 . . . . 0.0 110.96 -175.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.539 HD13 ' H ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -98.3 -28.71 3.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.079 -179.461 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.656 ' HB3' ' HB2' ' A' ' 12' ' ' ASN . 42.6 t -130.36 -26.9 2.26 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.379 -169.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.05 -128.61 4.93 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.249 -0.977 . . . . 0.0 112.339 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.547 0 O-C-N 121.911 -0.758 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.817 0 N-CA-C 112.121 -0.392 . . . . 0.0 112.121 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 2.6 p -134.17 53.84 1.98 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.12 0.486 . . . . 0.0 110.481 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 55.8 m -71.18 -0.16 9.13 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.1 m -98.74 17.04 20.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.131 0.491 . . . . 0.0 110.36 175.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -128.33 128.58 23.65 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.021 -175.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.515 ' O ' HG23 ' A' ' 10' ' ' VAL . 52.4 Cg_exo -56.06 -42.31 67.85 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.878 2.385 . . . . 0.0 113.166 -176.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.04 -42.86 99.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.971 0.415 . . . . 0.0 111.328 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 66.1 m -68.93 -25.13 64.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.899 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -77.93 -29.95 50.23 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.619 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 6' ' ' PRO . 85.7 t -68.03 -50.14 61.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.113 0.483 . . . . 0.0 109.878 175.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -68.25 -30.08 69.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.111 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.556 ' O ' ' HB3' ' A' ' 16' ' ' CYS . 69.2 m-80 -125.6 78.42 68.6 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.719 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -89.2 -26.47 0.46 Allowed 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 122.49 2.127 . . . . 0.0 114.31 -173.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.446 ' ND1' HG23 ' A' ' 15' ' ' ILE . 18.1 p80 -100.01 -26.61 13.92 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.882 0.372 . . . . 0.0 111.95 -173.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.446 HG23 ' ND1' ' A' ' 14' ' ' HIS . 4.1 pt -99.46 -34.39 4.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.257 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.556 ' HB3' ' O ' ' A' ' 12' ' ' ASN . 40.6 t -111.34 -64.19 1.31 Allowed 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.938 -1.028 . . . . 0.0 112.154 -166.266 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -140.15 79.29 0.29 Allowed Glycine 0 C--N 1.318 -0.421 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.662 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.553 0 O-C-N 121.755 -0.85 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.915 0 N-CA-C 112.1 -0.4 . . . . 0.0 112.1 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 12.6 t -67.78 -29.57 68.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.767 0.318 . . . . 0.0 110.487 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 86.3 m -71.19 6.71 1.54 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.6 t -98.93 15.12 26.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.987 0.422 . . . . 0.0 110.101 175.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -129.61 132.53 24.27 Favored Pre-proline 0 CA--C 1.518 -0.258 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.544 -175.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.588 ' O ' HG23 ' A' ' 10' ' ' VAL . 51.7 Cg_exo -55.6 -47.11 27.24 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.927 2.418 . . . . 0.0 112.996 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.51 -40.02 95.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.855 0.359 . . . . 0.0 111.398 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.6 t -69.61 -27.17 64.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.736 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -77.37 -23.86 50.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.87 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 6' ' ' PRO . 72.2 t -77.3 -50.93 19.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.778 0.323 . . . . 0.0 110.23 177.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.8 m-20 -69.24 -27.73 65.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.75 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.545 ' CB ' ' HB3' ' A' ' 16' ' ' CYS . 74.6 m-20 -122.21 77.14 42.92 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.482 177.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -87.49 -38.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.185 1.923 . . . . 0.0 114.978 -168.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -98.77 -9.21 24.77 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.376 0.608 . . . . 0.0 111.276 -174.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.9 pt -108.45 -41.02 4.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.583 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.545 ' HB3' ' CB ' ' A' ' 12' ' ' ASN . 44.7 t -115.04 -26.99 7.5 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.583 -170.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -99.37 -174.16 31.25 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.378 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.647 0 CA-C-N 117.737 0.768 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.885 0 N-CA-C 112.371 -0.292 . . . . 0.0 112.371 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.8 p -132.15 39.13 3.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.003 0.43 . . . . 0.0 110.783 178.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 84.8 m -73.37 -9.6 58.87 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 54.9 m -98.51 23.79 8.15 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.123 0.487 . . . . 0.0 110.574 174.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.455 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . 9.6 m80 -130.37 118.21 18.06 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.829 -176.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 5' ' ' HIS . 3.8 Cg_endo -51.01 -47.05 27.46 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.441 2.761 . . . . 0.0 113.631 -174.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.02 -41.43 95.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.798 0.333 . . . . 0.0 111.215 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.8 t -66.82 -26.38 66.9 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.167 178.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -72.83 -15.11 61.63 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.672 0.272 . . . . 0.0 111.122 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.422 ' O ' ' HG3' ' A' ' 13' ' ' PRO . 59.6 t -83.28 -49.05 17.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.621 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.425 ' C ' ' HD3' ' A' ' 13' ' ' PRO . 2.0 p-10 -78.75 -21.54 47.81 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.816 0.341 . . . . 0.0 110.86 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.678 ' HB3' ' CB ' ' A' ' 16' ' ' CYS . 37.4 m-20 -122.23 74.81 40.83 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.156 174.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.472 ' O ' ' N ' ' A' ' 18' ' ' NH2 . 10.3 Cg_exo -77.55 -58.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.028 2.486 . . . . 0.0 113.946 -172.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 49.6 p-80 -98.38 -12.45 21.42 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.481 -175.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.573 HD12 ' H ' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -97.97 -2.74 9.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.914 0.388 . . . . 0.0 110.27 -179.194 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.678 ' CB ' ' HB3' ' A' ' 12' ' ' ASN . 52.5 t -143.83 -67.98 0.34 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.079 -175.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -98.57 18.18 57.32 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.005 -1.093 . . . . 0.0 112.663 -175.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' NH2 . . . . . 0.472 ' N ' ' O ' ' A' ' 13' ' ' PRO . . . . . . . . 0 C--N 1.32 -0.676 0 O-C-N 121.81 -0.818 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.761 0 N-CA-C 112.097 -0.401 . . . . 0.0 112.097 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 4.6 p -115.57 50.41 1.01 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.958 0.408 . . . . 0.0 110.77 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 67.9 m -71.52 7.47 1.4 Allowed 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.0 t -99.17 5.71 46.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.055 0.455 . . . . 0.0 110.226 175.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 8.0 m80 -121.62 132.82 24.15 Favored Pre-proline 0 C--O 1.232 0.134 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.715 -174.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 5' ' ' HIS . 54.0 Cg_exo -54.8 -39.63 88.86 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.176 2.584 . . . . 0.0 113.501 -177.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.496 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -65.73 -39.5 91.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.887 0.375 . . . . 0.0 111.262 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.509 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 46.9 m -73.2 -23.11 60.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.532 178.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -85.12 -22.85 28.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.292 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.496 HG12 ' O ' ' A' ' 7' ' ' ALA . 6.2 p -85.67 -36.11 10.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.723 0.297 . . . . 0.0 110.451 -178.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 -74.61 -20.12 60.04 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 173.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.674 ' CB ' ' HB3' ' A' ' 16' ' ' CYS . 73.0 m-80 -135.41 73.64 62.58 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.678 -177.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -76.8 -43.26 0.27 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.827 2.351 . . . . 0.0 114.309 -173.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 -97.77 -17.02 19.61 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -173.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.504 HG12 ' HB3' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -99.38 -30.58 3.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.098 0.475 . . . . 0.0 110.966 179.492 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.674 ' HB3' ' CB ' ' A' ' 12' ' ' ASN . 43.5 t -130.63 -3.38 4.2 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.832 -170.015 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -110.18 -176.73 20.92 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.262 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.643 0 CA-C-N 117.648 0.724 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.666 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.528 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 2.9 p 39.75 53.13 2.54 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.65 0.78 . . . . 0.0 112.956 178.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 69.6 m -75.82 1.73 14.15 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.5 t -99.43 18.27 18.2 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.265 0.555 . . . . 0.0 109.61 174.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.2 m80 -131.3 123.24 19.51 Favored Pre-proline 0 C--N 1.334 -0.095 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.36 -174.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.423 ' O ' HG23 ' A' ' 10' ' ' VAL . 79.5 Cg_exo -49.26 -42.51 40.01 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.305 2.67 . . . . 0.0 113.322 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.64 -46.48 87.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.197 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.58 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 24.3 m -76.35 -11.99 59.99 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.29 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -83.78 -32.71 25.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.894 0.378 . . . . 0.0 110.172 177.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 6' ' ' PRO . 51.2 t -84.86 -46.86 17.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.52 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.4 m-20 -69.04 -32.69 72.36 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.096 0.474 . . . . 0.0 110.364 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.608 ' HB2' ' HB3' ' A' ' 16' ' ' CYS . 7.2 m120 -118.09 77.72 12.76 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.422 176.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -88.57 -33.65 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.23 1.954 . . . . 0.0 114.323 -170.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -98.41 -13.29 20.68 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.353 -175.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.623 HD13 ' H ' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -106.97 -32.1 2.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.195 0.521 . . . . 0.0 110.695 176.047 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.608 ' HB3' ' HB2' ' A' ' 12' ' ' ASN . 34.9 t -126.56 11.35 7.34 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.658 -169.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -135.67 -37.03 0.2 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.403 -0.904 . . . . 0.0 112.035 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.53 0 O-C-N 121.799 -0.824 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.897 0 N-CA-C 111.746 -0.542 . . . . 0.0 111.746 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.417 ' HA ' ' NE2' ' A' ' 5' ' ' HIS . 7.6 t -81.79 -19.41 41.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 117.252 0.526 . . . . 0.0 109.678 177.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 80.2 m -77.63 17.5 0.53 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.994 175.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.0 m -104.8 6.52 34.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.249 176.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.417 ' NE2' ' HA ' ' A' ' 2' ' ' CYS . 0.9 OUTLIER -127.82 133.37 25.04 Favored Pre-proline 0 C--O 1.232 0.14 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 -176.046 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.543 ' O ' HG23 ' A' ' 10' ' ' VAL . 24.3 Cg_endo -61.64 -34.17 84.9 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.381 2.054 . . . . 0.0 112.036 177.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.85 -44.95 79.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.123 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 47.1 t -68.52 -27.33 66.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.574 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -71.68 -22.06 61.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.846 176.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 6' ' ' PRO . 93.7 t -73.47 -51.34 25.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.73 0.3 . . . . 0.0 110.346 176.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.8 m-20 -71.02 -31.86 68.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.201 0.524 . . . . 0.0 110.526 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.583 ' O ' ' HB3' ' A' ' 16' ' ' CYS . 74.4 m-80 -119.56 77.5 20.08 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.401 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -90.13 -36.74 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.73 2.287 . . . . 0.0 114.057 -174.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 32.5 p-80 -99.79 -17.63 17.58 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.848 0.356 . . . . 0.0 111.314 -176.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.524 HD13 ' H ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -99.38 -31.95 3.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.31 0.576 . . . . 0.0 111.127 -179.307 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.583 ' HB3' ' O ' ' A' ' 12' ' ' ASN . 36.2 t -116.02 -74.58 0.6 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.835 -170.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -137.21 94.13 0.22 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.421 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.581 0 O-C-N 121.932 -0.746 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.884 0 N-CA-C 111.932 -0.467 . . . . 0.0 111.932 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.444 ' HA ' ' NE2' ' A' ' 5' ' ' HIS . 31.6 t -90.03 -13.75 35.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.003 0.43 . . . . 0.0 110.554 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 75.4 m -75.17 10.77 1.38 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.826 0.346 . . . . 0.0 111.486 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 37.2 m -99.9 8.19 44.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.071 177.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.444 ' NE2' ' HA ' ' A' ' 2' ' ' CYS . 1.2 m-70 -125.11 134.37 25.67 Favored Pre-proline 0 C--O 1.232 0.161 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 -175.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.446 ' O ' HG23 ' A' ' 10' ' ' VAL . 70.4 Cg_exo -52.43 -53.02 7.61 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.062 2.508 . . . . 0.0 113.497 -177.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.09 -38.05 87.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.661 -178.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.0 t -68.12 -28.55 67.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.872 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -75.07 -22.37 58.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.326 177.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 6' ' ' PRO . 56.1 t -77.64 -56.47 7.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.854 0.359 . . . . 0.0 110.581 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -66.83 -24.87 66.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.88 0.372 . . . . 0.0 111.16 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.487 ' CB ' ' HB3' ' A' ' 16' ' ' CYS . 73.5 m-80 -122.88 78.62 49.82 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.12 178.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -96.3 -25.73 0.1 Allowed 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.663 2.242 . . . . 0.0 115.081 -170.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -98.46 -21.82 16.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.29 0.567 . . . . 0.0 111.093 -176.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.5 pt -105.22 -37.07 3.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.643 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.487 ' HB3' ' CB ' ' A' ' 12' ' ' ASN . 42.8 t -117.68 -12.18 10.31 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.746 -1.115 . . . . 0.0 111.05 -170.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -99.65 168.19 21.47 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.248 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.642 0 CA-C-N 117.738 0.769 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.845 0 N-CA-C 112.601 -0.2 . . . . 0.0 112.601 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.8 t -63.52 -26.05 68.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.895 0.378 . . . . 0.0 110.558 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 72.1 m -67.1 -2.95 6.25 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.2 t -98.63 22.84 9.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.999 0.428 . . . . 0.0 110.291 177.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.405 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . 15.4 m80 -131.74 124.21 19.7 Favored Pre-proline 0 C--O 1.231 0.089 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.24 -176.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 5' ' ' HIS . 10.0 Cg_endo -55.41 -40.48 85.3 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.149 2.566 . . . . 0.0 113.54 -176.127 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.49 -34.39 70.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.846 0.355 . . . . 0.0 110.873 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 42.6 t -71.03 -24.4 62.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.173 0.511 . . . . 0.0 110.666 178.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -79.52 -12.3 59.87 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.136 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.7 t -77.42 -58.34 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.731 0.3 . . . . 0.0 110.369 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -76.04 -12.13 60.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.819 0.343 . . . . 0.0 111.152 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.656 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 82.3 m-20 -128.55 72.42 80.71 Favored Pre-proline 0 N--CA 1.465 0.285 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.133 174.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -83.16 -43.84 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.43 2.086 . . . . 0.0 114.913 -170.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -97.74 -19.0 18.49 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.909 0.385 . . . . 0.0 111.915 -171.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.9 pt -99.07 -32.35 3.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.041 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.656 ' HB3' ' HB3' ' A' ' 12' ' ' ASN . 22.3 t -127.67 -13.05 5.4 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.508 -169.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -99.82 -59.98 0.85 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.344 -0.931 . . . . 0.0 112.454 -177.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.532 0 O-C-N 121.907 -0.761 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.861 0 N-CA-C 111.809 -0.516 . . . . 0.0 111.809 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 13.1 t -116.25 -33.82 4.86 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 177.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 87.8 m -70.93 5.98 1.75 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 178.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.5 p -98.96 14.72 28.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.939 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.428 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 21.9 m80 -131.26 142.73 46.52 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.926 -176.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.518 ' O ' HG23 ' A' ' 10' ' ' VAL . 46.6 Cg_exo -57.71 -51.13 8.74 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.9 2.4 . . . . 0.0 113.21 -178.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.22 -45.69 92.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.744 -177.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.3 t -64.92 -28.23 69.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.877 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -73.39 -29.91 62.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.656 176.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 6' ' ' PRO . 64.4 t -73.58 -48.48 40.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.208 178.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 -61.77 -42.18 98.66 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.598 178.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.546 ' CB ' ' HB3' ' A' ' 16' ' ' CYS . 64.5 m-20 -115.01 78.7 5.65 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.002 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -64.59 -68.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.715 2.277 . . . . 0.0 113.857 -172.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -98.35 2.03 47.59 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.077 0.465 . . . . 0.0 111.31 -175.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.434 HD12 ' H ' ' A' ' 15' ' ' ILE . 3.0 mp -99.15 -18.09 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.449 177.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.546 ' HB3' ' CB ' ' A' ' 12' ' ' ASN . 21.9 t -140.69 -36.09 0.47 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.598 -172.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -98.85 -137.16 9.66 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.532 -177.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.539 0 O-C-N 121.783 -0.833 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.908 0 N-CA-C 111.946 -0.462 . . . . 0.0 111.946 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.3 p -147.73 40.08 0.98 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.9 0.381 . . . . 0.0 110.416 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 44.5 m -67.77 5.15 0.91 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 p -98.85 15.31 25.9 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.97 0.414 . . . . 0.0 110.961 175.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.1 m80 -128.54 132.79 24.56 Favored Pre-proline 0 CA--C 1.519 -0.213 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.795 -175.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -51.52 -42.35 56.09 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.215 2.61 . . . . 0.0 113.388 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.526 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -65.69 -42.88 90.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.85 0.357 . . . . 0.0 111.3 -179.275 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.526 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 79.4 m -69.61 -20.58 63.62 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.81 0.338 . . . . 0.0 110.938 178.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -85.57 -23.88 27.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.447 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 7' ' ' ALA . 6.2 p -84.64 -40.12 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.265 -176.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -80.21 -9.27 59.72 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.263 0.554 . . . . 0.0 110.166 175.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.59 ' CB ' ' HB3' ' A' ' 16' ' ' CYS . 68.4 m-80 -137.06 67.05 55.39 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.09 178.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -84.72 -30.5 0.57 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.285 1.99 . . . . 0.0 113.99 -172.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -99.35 -23.26 15.22 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.888 0.375 . . . . 0.0 111.582 -174.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.473 HG13 ' H ' ' A' ' 16' ' ' CYS . 5.2 pt -98.47 -46.77 12.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.481 0.657 . . . . 0.0 110.738 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.59 ' HB3' ' CB ' ' A' ' 12' ' ' ASN . 16.8 t -98.86 -27.53 13.87 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.985 -173.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -99.85 -9.23 49.83 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.912 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.478 0 O-C-N 121.698 -0.884 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.913 0 N-CA-C 112.276 -0.33 . . . . 0.0 112.276 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.8 p 40.36 55.91 2.73 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.795 0.838 . . . . 0.0 112.578 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.3 m -75.15 -4.5 39.11 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 45.3 m -98.74 18.71 16.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.931 0.395 . . . . 0.0 110.745 176.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.3 m80 -127.09 124.43 23.85 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.604 -174.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.504 ' O ' HG23 ' A' ' 10' ' ' VAL . 61.7 Cg_exo -54.05 -40.0 83.18 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.171 2.58 . . . . 0.0 113.383 -176.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.53 -43.23 97.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.866 0.365 . . . . 0.0 111.27 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.4 m -69.86 -25.01 63.52 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.056 0.455 . . . . 0.0 110.291 178.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -78.75 -13.13 59.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.013 178.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 6' ' ' PRO . 60.5 t -75.01 -52.75 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 175.062 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.0 m-20 -70.49 -31.71 68.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.559 178.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.531 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 74.7 m-80 -124.63 76.47 63.92 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.649 -178.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.491 ' HD2' HD11 ' A' ' 15' ' ' ILE . 36.6 Cg_endo -75.57 -59.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.64 2.227 . . . . 0.0 114.545 -172.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 24.5 p80 -98.46 -4.76 33.79 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.057 0.456 . . . . 0.0 111.172 -174.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.491 HD11 ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -98.61 -22.84 4.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.575 178.479 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.531 ' HB3' ' HB3' ' A' ' 12' ' ' ASN . 50.7 t -137.92 -17.31 1.24 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.863 -170.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -104.31 -130.31 6.81 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.147 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.529 0 CA-C-N 117.924 0.862 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.835 0 N-CA-C 111.788 -0.525 . . . . 0.0 111.788 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 7.9 p 39.26 50.94 2.02 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.562 0.745 . . . . 0.0 112.579 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 71.6 m -72.0 -2.06 16.85 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -177.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.8 p -98.86 21.11 11.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.042 0.449 . . . . 0.0 110.66 174.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.421 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 2.8 m80 -127.31 131.15 23.7 Favored Pre-proline 0 C--O 1.233 0.193 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.181 -175.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.55 ' O ' HG23 ' A' ' 10' ' ' VAL . 64.9 Cg_exo -53.2 -49.53 17.16 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.0 2.467 . . . . 0.0 113.026 -178.08 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.56 -39.13 86.84 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.061 -178.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.421 ' SG ' ' HB2' ' A' ' 5' ' ' HIS . 36.8 m -70.32 -29.01 65.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.87 0.367 . . . . 0.0 110.606 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 61.7 m-20 -76.62 -20.18 57.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.291 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 6' ' ' PRO . 57.7 t -69.96 -51.8 36.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.929 0.395 . . . . 0.0 110.427 178.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.408 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 62.1 m-80 -74.69 -32.02 62.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.149 0.5 . . . . 0.0 110.987 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.544 ' O ' ' HB3' ' A' ' 16' ' ' CYS . 74.4 m-80 -120.59 77.19 27.8 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.558 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 11' ' ' ASN . 6.1 Cg_exo -85.28 -42.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.1 2.533 . . . . 0.0 113.912 -172.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -98.05 -16.29 19.66 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.882 0.372 . . . . 0.0 111.362 -174.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.488 HD13 ' H ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -98.66 -27.66 3.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.006 178.349 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.544 ' HB3' ' O ' ' A' ' 12' ' ' ASN . 50.8 t -130.49 -6.69 4.19 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.079 -169.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -99.84 -53.48 1.11 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.166 -1.016 . . . . 0.0 112.262 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.589 0 O-C-N 121.846 -0.796 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.74 0 N-CA-C 112.102 -0.399 . . . . 0.0 112.102 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.6 p -133.62 45.87 2.62 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.915 0.388 . . . . 0.0 110.664 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 92.2 m -70.76 5.81 1.77 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 p -99.04 18.39 17.44 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.727 0.299 . . . . 0.0 110.66 174.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 14.5 m80 -130.75 136.29 28.7 Favored Pre-proline 0 C--O 1.234 0.238 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.546 -176.036 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 5' ' ' HIS . 49.2 Cg_exo -56.93 -40.93 80.54 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 123.035 2.49 . . . . 0.0 113.244 -178.038 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.502 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -69.52 -37.21 77.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.206 -178.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.551 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 80.1 m -71.69 -22.3 61.67 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.793 0.33 . . . . 0.0 110.888 177.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -82.93 -25.2 32.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.93 179.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.502 HG12 ' O ' ' A' ' 7' ' ' ALA . 5.0 p -85.79 -39.62 13.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.361 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 25.6 m-20 -71.02 -16.49 62.62 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.053 0.454 . . . . 0.0 110.345 174.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.619 ' CB ' ' HB3' ' A' ' 16' ' ' CYS . 70.9 m-80 -137.7 77.63 38.7 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.298 -179.211 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -65.72 -66.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.167 2.578 . . . . 0.0 114.504 -172.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -97.48 -2.41 42.06 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.921 0.391 . . . . 0.0 111.486 -172.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.4 HD13 ' H ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -99.38 -25.82 3.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.893 178.858 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.619 ' HB3' ' CB ' ' A' ' 12' ' ' ASN . 36.9 t -136.52 -28.23 1.01 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.329 -169.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -105.16 13.27 48.67 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.275 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.513 0 O-C-N 121.972 -0.722 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.609 0 N-CA-C 111.933 -0.467 . . . . 0.0 111.933 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 23.6 p 41.83 45.86 3.25 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.675 0.79 . . . . 0.0 112.529 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 67.6 m -73.82 0.62 12.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.706 0.289 . . . . 0.0 111.601 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.2 p -98.71 17.31 19.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.525 175.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.1 m80 -127.64 131.96 24.09 Favored Pre-proline 0 N--CA 1.462 0.125 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.424 -175.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.454 ' O ' HG23 ' A' ' 10' ' ' VAL . 9.8 Cg_endo -57.83 -41.42 69.73 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.195 2.597 . . . . 0.0 113.444 -175.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.18 -42.22 93.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.077 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 58.9 m -66.45 -22.35 66.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.102 0.477 . . . . 0.0 110.648 177.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -85.43 -6.85 59.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.42 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 6' ' ' PRO . 48.4 t -82.12 -55.02 8.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 176.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -75.73 -20.78 58.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.178 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.573 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 71.9 m-20 -125.34 79.56 66.39 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.15 174.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -79.91 -56.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.021 2.481 . . . . 0.0 114.915 -170.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 23.2 p-80 -97.55 -10.11 25.83 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.575 -172.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.593 HD13 ' H ' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -98.3 -31.73 3.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.259 0.552 . . . . 0.0 110.574 179.06 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.573 ' HB3' ' HB3' ' A' ' 12' ' ' ASN . 50.6 t -122.08 -19.07 6.73 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.085 -170.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -118.35 -18.07 5.07 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.167 178.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.533 0 O-C-N 121.908 -0.76 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.806 0 N-CA-C 111.921 -0.472 . . . . 0.0 111.921 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 4.4 p -119.9 49.95 1.33 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.844 0.354 . . . . 0.0 111.036 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.9 m -64.66 -2.42 2.43 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.1 p -99.59 20.44 13.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.808 0.337 . . . . 0.0 111.576 176.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 6.0 m80 -127.48 137.78 31.43 Favored Pre-proline 0 N--CA 1.462 0.166 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.225 -176.22 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 5' ' ' HIS . 58.2 Cg_exo -54.41 -48.57 20.77 Favored 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 123.033 2.488 . . . . 0.0 113.504 -176.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.426 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -67.92 -36.53 80.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.103 -178.161 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.599 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 62.5 m -68.75 -29.2 67.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.715 178.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -80.15 -30.95 38.97 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.426 HG12 ' O ' ' A' ' 7' ' ' ALA . 9.1 p -78.24 -37.72 22.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.949 -176.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -83.69 -1.17 53.49 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.896 0.379 . . . . 0.0 110.571 175.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.74 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 70.4 m-80 -141.13 71.4 27.89 Favored Pre-proline 0 N--CA 1.467 0.423 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.135 177.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -79.82 -44.57 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.767 2.311 . . . . 0.0 114.479 -170.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 30.2 p-80 -98.34 -15.09 19.87 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.803 0.335 . . . . 0.0 111.413 -174.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.516 HD13 ' H ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -99.3 -30.05 3.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.246 -179.147 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.74 ' HB3' ' HB3' ' A' ' 12' ' ' ASN . 33.7 t -130.06 -22.01 2.91 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.41 -169.072 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -99.31 178.02 30.12 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.26 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.562 0 CA-C-N 117.902 0.851 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.871 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.6 p -140.81 33.41 1.79 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.779 0.323 . . . . 0.0 110.903 178.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 85.4 m -70.63 -0.48 8.77 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -178.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.1 m -98.55 23.26 8.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.806 0.336 . . . . 0.0 110.737 175.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.0 m80 -132.48 129.4 21.44 Favored Pre-proline 0 C--O 1.233 0.2 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.38 -176.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.422 ' O ' HG23 ' A' ' 10' ' ' VAL . 86.7 Cg_exo -49.04 -43.08 37.31 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.307 2.671 . . . . 0.0 113.475 -177.259 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.46 -46.39 90.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.362 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.497 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 82.1 m -71.46 -15.72 62.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.749 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -85.19 -30.74 23.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.752 0.31 . . . . 0.0 110.666 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 6' ' ' PRO . 48.8 t -82.99 -48.69 17.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.243 177.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 31.4 m-20 -65.48 -34.08 77.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.256 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.669 ' HB2' ' HB3' ' A' ' 16' ' ' CYS . 6.2 m120 -123.69 79.46 55.92 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.801 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -81.67 -42.88 0.1 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.351 2.034 . . . . 0.0 114.688 -170.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 27.2 p80 -98.56 -13.41 20.44 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.608 -173.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.586 HD13 ' H ' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -101.49 -32.83 3.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.72 176.716 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.669 ' HB3' ' HB2' ' A' ' 12' ' ' ASN . 20.0 t -127.12 2.67 6.46 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.675 -170.097 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -111.8 -46.98 0.75 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.237 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.504 0 O-C-N 121.822 -0.811 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.944 0 N-CA-C 112.05 -0.42 . . . . 0.0 112.05 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.7 t -123.58 -19.96 5.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.882 0.372 . . . . 0.0 110.263 178.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 95.3 m -72.32 6.06 2.51 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -177.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.8 p -98.87 18.97 15.83 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.788 175.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.9 m80 -129.99 131.55 23.55 Favored Pre-proline 0 C--O 1.232 0.176 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.229 -177.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.432 ' O ' HG23 ' A' ' 10' ' ' VAL . 77.3 Cg_exo -52.89 -52.93 7.71 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.097 2.531 . . . . 0.0 113.574 -176.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.78 -39.44 94.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.45 -178.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.8 t -64.79 -26.59 68.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.019 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -78.15 -22.96 47.96 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.273 177.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 6' ' ' PRO . 59.9 t -79.17 -48.88 20.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.884 0.373 . . . . 0.0 110.702 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.408 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 62.3 m-80 -73.05 -27.76 61.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.987 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.551 ' CB ' ' HB3' ' A' ' 16' ' ' CYS . 76.9 m-20 -119.58 80.4 23.02 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.824 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 11' ' ' ASN . 1.0 OUTLIER -91.1 -38.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.891 2.394 . . . . 0.0 114.4 -172.486 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 56.1 p-80 -98.53 -12.45 21.22 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.762 -177.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.565 HD13 ' H ' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -101.84 -31.67 3.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.488 176.092 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.551 ' HB3' ' CB ' ' A' ' 12' ' ' ASN . 44.9 t -131.73 17.25 4.75 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.553 -170.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -99.08 -113.76 3.43 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.167 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.569 0 O-C-N 121.72 -0.871 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.825 0 N-CA-C 111.926 -0.469 . . . . 0.0 111.926 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.428 ' O ' ' HB3' ' A' ' 8' ' ' CYS . 2.0 p -139.7 30.38 2.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.841 0.353 . . . . 0.0 111.382 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 94.2 m -69.6 -4.04 17.55 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.1 m -99.79 12.06 37.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.563 0.221 . . . . 0.0 111.048 176.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 8.4 m80 -124.4 127.48 25.26 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.795 -174.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 5' ' ' HIS . 69.4 Cg_exo -55.04 -38.07 93.58 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.271 2.647 . . . . 0.0 113.925 -175.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.676 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -67.9 -43.04 80.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.099 0.476 . . . . 0.0 110.777 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.663 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 52.6 t -70.28 -19.58 63.09 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.621 178.41 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 63.3 m-20 -83.24 -17.8 41.41 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.676 HG12 ' O ' ' A' ' 7' ' ' ALA . 4.8 p -84.04 -41.18 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.116 -176.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -88.83 -5.79 57.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.006 0.432 . . . . 0.0 110.126 175.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.729 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 74.7 m-20 -135.61 71.45 65.15 Favored Pre-proline 0 N--CA 1.465 0.292 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.199 174.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -85.69 -42.43 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.901 2.401 . . . . 0.0 114.088 -172.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 -98.21 -15.95 19.66 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.044 0.449 . . . . 0.0 111.079 -176.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.511 HD13 ' H ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -99.17 -30.58 3.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.894 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.729 ' HB3' ' HB3' ' A' ' 12' ' ' ASN . 35.4 t -134.63 4.14 3.33 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.479 -170.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -99.25 15.52 60.2 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.397 -0.906 . . . . 0.0 111.95 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.557 0 O-C-N 121.978 -0.719 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 87.2 m . . . . . 0 N--CA 1.468 0.438 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.5 p -99.06 24.47 7.79 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.703 0.287 . . . . 0.0 111.739 177.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -134.88 129.4 19.17 Favored Pre-proline 0 C--O 1.232 0.174 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.354 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.425 ' O ' HG23 ' A' ' 10' ' ' VAL . 9.2 Cg_endo -54.88 -37.1 93.03 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.104 2.536 . . . . 0.0 113.124 -178.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.57 -36.62 70.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.882 0.372 . . . . 0.0 111.18 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.525 ' HA ' HD21 ' A' ' 11' ' ' ASN . 45.7 t -72.93 -19.2 61.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.601 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -82.55 -11.31 58.54 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.081 176.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 6' ' ' PRO . 55.1 t -79.47 -53.08 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.716 0.293 . . . . 0.0 110.459 177.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.525 HD21 ' HA ' ' A' ' 8' ' ' CYS . 9.6 p30 -74.09 -26.71 60.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.05 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.708 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 72.6 m-20 -119.68 78.93 22.41 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.738 174.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 11' ' ' ASN . 10.1 Cg_exo -77.9 -59.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.924 2.416 . . . . 0.0 114.475 -170.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -97.92 -6.62 31.88 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.508 -172.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.582 HD13 ' H ' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -99.37 -30.72 3.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.857 176.858 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.708 ' HB3' ' HB3' ' A' ' 12' ' ' ASN . 52.4 t -127.35 -15.83 5.06 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.173 -170.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.357 -0.925 . . . . 0.0 111.819 177.757 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 97.0 m . . . . . 0 N--CA 1.462 0.172 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.4 p -99.65 16.66 22.75 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.143 0.497 . . . . 0.0 110.408 173.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -125.77 130.55 24.01 Favored Pre-proline 0 C--O 1.233 0.227 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.049 -175.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.444 ' O ' HG23 ' A' ' 10' ' ' VAL . 6.5 Cg_endo -52.34 -46.27 34.02 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.325 2.684 . . . . 0.0 113.518 -175.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.98 -44.97 94.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.838 0.351 . . . . 0.0 111.456 -178.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.49 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 11.9 m -71.9 -15.78 62.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.243 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -85.51 -25.69 26.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.664 0.268 . . . . 0.0 111.002 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 6' ' ' PRO . 62.0 t -82.08 -52.44 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.367 178.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.418 ' N ' HD22 ' A' ' 11' ' ' ASN . 2.6 m120 -67.43 -31.18 71.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.564 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.656 ' HB2' ' HB3' ' A' ' 16' ' ' CYS . 5.1 m120 -119.4 77.29 18.6 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 177.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -83.57 -42.19 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.375 2.05 . . . . 0.0 115.088 -168.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 34.1 p-80 -98.38 -16.36 19.33 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.223 0.535 . . . . 0.0 110.96 -175.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.539 HD13 ' H ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -98.3 -28.71 3.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.079 -179.461 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.656 ' HB3' ' HB2' ' A' ' 12' ' ' ASN . 42.6 t -130.36 -26.9 2.26 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.379 -169.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.391 0 C-N-CA 120.249 -0.977 . . . . 0.0 112.339 -178.244 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 55.8 m . . . . . 0 N--CA 1.464 0.225 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.1 m -98.74 17.04 20.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.131 0.491 . . . . 0.0 110.36 175.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -128.33 128.58 23.65 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.021 -175.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.515 ' O ' HG23 ' A' ' 10' ' ' VAL . 52.4 Cg_exo -56.06 -42.31 67.85 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.878 2.385 . . . . 0.0 113.166 -176.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.04 -42.86 99.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.971 0.415 . . . . 0.0 111.328 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 66.1 m -68.93 -25.13 64.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.899 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -77.93 -29.95 50.23 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.619 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 6' ' ' PRO . 85.7 t -68.03 -50.14 61.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.113 0.483 . . . . 0.0 109.878 175.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.409 HD22 ' N ' ' A' ' 11' ' ' ASN . 2.3 m120 -68.25 -30.08 69.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.111 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.556 ' O ' ' HB3' ' A' ' 16' ' ' CYS . 69.2 m-80 -125.6 78.42 68.6 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.719 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -89.2 -26.47 0.46 Allowed 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 122.49 2.127 . . . . 0.0 114.31 -173.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.446 ' ND1' HG23 ' A' ' 15' ' ' ILE . 18.1 p80 -100.01 -26.61 13.92 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.882 0.372 . . . . 0.0 111.95 -173.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.446 HG23 ' ND1' ' A' ' 14' ' ' HIS . 4.1 pt -99.46 -34.39 4.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.257 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.556 ' HB3' ' O ' ' A' ' 12' ' ' ASN . 40.6 t -111.34 -64.19 1.31 Allowed 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.938 -1.028 . . . . 0.0 112.154 -166.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.421 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.662 -177.995 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 86.3 m . . . . . 0 N--CA 1.464 0.237 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.6 t -98.93 15.12 26.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.987 0.422 . . . . 0.0 110.101 175.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -129.61 132.53 24.27 Favored Pre-proline 0 CA--C 1.518 -0.258 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.544 -175.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.588 ' O ' HG23 ' A' ' 10' ' ' VAL . 51.7 Cg_exo -55.6 -47.11 27.24 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.927 2.418 . . . . 0.0 112.996 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.51 -40.02 95.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.855 0.359 . . . . 0.0 111.398 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.6 t -69.61 -27.17 64.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.736 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -77.37 -23.86 50.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.87 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 6' ' ' PRO . 72.2 t -77.3 -50.93 19.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.778 0.323 . . . . 0.0 110.23 177.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.44 ' N ' HD22 ' A' ' 11' ' ' ASN . 2.2 m120 -69.24 -27.73 65.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.75 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.545 ' CB ' ' HB3' ' A' ' 16' ' ' CYS . 74.6 m-20 -122.21 77.14 42.92 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.482 177.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -87.49 -38.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.185 1.923 . . . . 0.0 114.978 -168.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -98.77 -9.21 24.77 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.376 0.608 . . . . 0.0 111.276 -174.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.9 pt -108.45 -41.02 4.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.583 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.545 ' HB3' ' CB ' ' A' ' 12' ' ' ASN . 44.7 t -115.04 -26.99 7.5 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.583 -170.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.419 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.378 -179.156 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 84.8 m . . . . . 0 N--CA 1.458 -0.067 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 54.9 m -98.51 23.79 8.15 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.123 0.487 . . . . 0.0 110.574 174.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.455 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . 9.6 m80 -130.37 118.21 18.06 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.829 -176.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 5' ' ' HIS . 3.8 Cg_endo -51.01 -47.05 27.46 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.441 2.761 . . . . 0.0 113.631 -174.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.02 -41.43 95.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.798 0.333 . . . . 0.0 111.215 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.645 ' HA ' HD21 ' A' ' 11' ' ' ASN . 39.8 t -66.82 -26.38 66.9 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.167 178.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -72.83 -15.11 61.63 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.672 0.272 . . . . 0.0 111.122 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.422 ' O ' ' HG3' ' A' ' 13' ' ' PRO . 59.6 t -83.28 -49.05 17.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.621 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.645 HD21 ' HA ' ' A' ' 8' ' ' CYS . 11.7 p30 -78.75 -21.54 47.81 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.816 0.341 . . . . 0.0 110.86 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.678 ' HB3' ' CB ' ' A' ' 16' ' ' CYS . 37.4 m-20 -122.23 74.81 40.83 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.156 174.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.425 ' HD3' ' C ' ' A' ' 11' ' ' ASN . 10.3 Cg_exo -77.55 -58.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.028 2.486 . . . . 0.0 113.946 -172.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 49.6 p-80 -98.38 -12.45 21.42 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.481 -175.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.573 HD12 ' H ' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -97.97 -2.74 9.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.914 0.388 . . . . 0.0 110.27 -179.194 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.678 ' CB ' ' HB3' ' A' ' 12' ' ' ASN . 52.5 t -143.83 -67.98 0.34 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.079 -175.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 C-N-CA 120.005 -1.093 . . . . 0.0 112.663 -175.756 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 67.9 m . . . . . 0 N--CA 1.467 0.376 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.0 t -99.17 5.71 46.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.055 0.455 . . . . 0.0 110.226 175.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 8.0 m80 -121.62 132.82 24.15 Favored Pre-proline 0 C--O 1.232 0.134 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.715 -174.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 5' ' ' HIS . 54.0 Cg_exo -54.8 -39.63 88.86 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.176 2.584 . . . . 0.0 113.501 -177.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.496 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -65.73 -39.5 91.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.887 0.375 . . . . 0.0 111.262 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.509 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 46.9 m -73.2 -23.11 60.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.532 178.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -85.12 -22.85 28.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.292 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.496 HG12 ' O ' ' A' ' 7' ' ' ALA . 6.2 p -85.67 -36.11 10.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.723 0.297 . . . . 0.0 110.451 -178.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.43 HD22 ' N ' ' A' ' 11' ' ' ASN . 2.2 m120 -74.61 -20.12 60.04 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 173.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.674 ' CB ' ' HB3' ' A' ' 16' ' ' CYS . 73.0 m-80 -135.41 73.64 62.58 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.678 -177.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -76.8 -43.26 0.27 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.827 2.351 . . . . 0.0 114.309 -173.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 -97.77 -17.02 19.61 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -173.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.504 HG12 ' HB3' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -99.38 -30.58 3.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.098 0.475 . . . . 0.0 110.966 179.492 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.674 ' HB3' ' CB ' ' A' ' 12' ' ' ASN . 43.5 t -130.63 -3.38 4.2 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.832 -170.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.429 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.262 178.77 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 69.6 m . . . . . 0 CA--C 1.528 0.11 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.5 t -99.43 18.27 18.2 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.265 0.555 . . . . 0.0 109.61 174.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.2 m80 -131.3 123.24 19.51 Favored Pre-proline 0 C--N 1.334 -0.095 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.36 -174.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.423 ' O ' HG23 ' A' ' 10' ' ' VAL . 79.5 Cg_exo -49.26 -42.51 40.01 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.305 2.67 . . . . 0.0 113.322 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.64 -46.48 87.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.197 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.58 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 24.3 m -76.35 -11.99 59.99 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.29 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -83.78 -32.71 25.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.894 0.378 . . . . 0.0 110.172 177.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 6' ' ' PRO . 51.2 t -84.86 -46.86 17.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.52 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.418 ' N ' HD22 ' A' ' 11' ' ' ASN . 2.4 m120 -69.04 -32.69 72.36 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.096 0.474 . . . . 0.0 110.364 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.608 ' HB2' ' HB3' ' A' ' 16' ' ' CYS . 7.2 m120 -118.09 77.72 12.76 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.422 176.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -88.57 -33.65 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.23 1.954 . . . . 0.0 114.323 -170.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -98.41 -13.29 20.68 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.353 -175.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.623 HD13 ' H ' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -106.97 -32.1 2.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.195 0.521 . . . . 0.0 110.695 176.047 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.608 ' HB3' ' HB2' ' A' ' 12' ' ' ASN . 34.9 t -126.56 11.35 7.34 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.658 -169.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.396 0 C-N-CA 120.403 -0.904 . . . . 0.0 112.035 179.384 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 80.2 m . . . . . 0 N--CA 1.455 -0.185 0 CA-C-O 120.823 0.344 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.0 m -104.8 6.52 34.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.249 176.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -127.82 133.37 25.04 Favored Pre-proline 0 C--O 1.232 0.14 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 -176.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.543 ' O ' HG23 ' A' ' 10' ' ' VAL . 24.3 Cg_endo -61.64 -34.17 84.9 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.381 2.054 . . . . 0.0 112.036 177.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.85 -44.95 79.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.123 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 47.1 t -68.52 -27.33 66.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.574 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -71.68 -22.06 61.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.846 176.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 6' ' ' PRO . 93.7 t -73.47 -51.34 25.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.73 0.3 . . . . 0.0 110.346 176.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.451 HD22 ' N ' ' A' ' 11' ' ' ASN . 2.1 m120 -71.02 -31.86 68.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.201 0.524 . . . . 0.0 110.526 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.583 ' O ' ' HB3' ' A' ' 16' ' ' CYS . 74.4 m-80 -119.56 77.5 20.08 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.401 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -90.13 -36.74 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.73 2.287 . . . . 0.0 114.057 -174.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 32.5 p-80 -99.79 -17.63 17.58 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.848 0.356 . . . . 0.0 111.314 -176.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.524 HD13 ' H ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -99.38 -31.95 3.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.31 0.576 . . . . 0.0 111.127 -179.307 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.583 ' HB3' ' O ' ' A' ' 12' ' ' ASN . 36.2 t -116.02 -74.58 0.6 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.835 -170.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.422 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.421 -179.063 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 75.4 m . . . . . 0 CA--C 1.524 -0.048 0 CA-C-O 120.826 0.346 . . . . 0.0 111.486 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 37.2 m -99.9 8.19 44.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.071 177.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -125.11 134.37 25.67 Favored Pre-proline 0 C--O 1.232 0.161 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 -175.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.446 ' O ' HG23 ' A' ' 10' ' ' VAL . 70.4 Cg_exo -52.43 -53.02 7.61 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.062 2.508 . . . . 0.0 113.497 -177.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.09 -38.05 87.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.661 -178.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.0 t -68.12 -28.55 67.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.872 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -75.07 -22.37 58.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.326 177.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 6' ' ' PRO . 56.1 t -77.64 -56.47 7.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.854 0.359 . . . . 0.0 110.581 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -66.83 -24.87 66.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.88 0.372 . . . . 0.0 111.16 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.487 ' CB ' ' HB3' ' A' ' 16' ' ' CYS . 73.5 m-80 -122.88 78.62 49.82 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.12 178.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -96.3 -25.73 0.1 Allowed 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.663 2.242 . . . . 0.0 115.081 -170.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -98.46 -21.82 16.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.29 0.567 . . . . 0.0 111.093 -176.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.5 pt -105.22 -37.07 3.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.643 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.487 ' HB3' ' CB ' ' A' ' 12' ' ' ASN . 42.8 t -117.68 -12.18 10.31 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.746 -1.115 . . . . 0.0 111.05 -170.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.248 -179.189 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 72.1 m . . . . . 0 N--CA 1.463 0.21 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.2 t -98.63 22.84 9.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.999 0.428 . . . . 0.0 110.291 177.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.405 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . 15.4 m80 -131.74 124.21 19.7 Favored Pre-proline 0 C--O 1.231 0.089 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.24 -176.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 5' ' ' HIS . 10.0 Cg_endo -55.41 -40.48 85.3 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.149 2.566 . . . . 0.0 113.54 -176.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.49 -34.39 70.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.846 0.355 . . . . 0.0 110.873 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 42.6 t -71.03 -24.4 62.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.173 0.511 . . . . 0.0 110.666 178.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -79.52 -12.3 59.87 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.136 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.7 t -77.42 -58.34 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.731 0.3 . . . . 0.0 110.369 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -76.04 -12.13 60.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.819 0.343 . . . . 0.0 111.152 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.656 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 82.3 m-20 -128.55 72.42 80.71 Favored Pre-proline 0 N--CA 1.465 0.285 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.133 174.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -83.16 -43.84 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.43 2.086 . . . . 0.0 114.913 -170.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -97.74 -19.0 18.49 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.909 0.385 . . . . 0.0 111.915 -171.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.9 pt -99.07 -32.35 3.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.041 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.656 ' HB3' ' HB3' ' A' ' 12' ' ' ASN . 22.3 t -127.67 -13.05 5.4 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.508 -169.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 C-N-CA 120.344 -0.931 . . . . 0.0 112.454 -177.632 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 87.8 m . . . . . 0 N--CA 1.462 0.148 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.5 p -98.96 14.72 28.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.939 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.428 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 21.9 m80 -131.26 142.73 46.52 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.926 -176.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.518 ' O ' HG23 ' A' ' 10' ' ' VAL . 46.6 Cg_exo -57.71 -51.13 8.74 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.9 2.4 . . . . 0.0 113.21 -178.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.22 -45.69 92.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.744 -177.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.3 t -64.92 -28.23 69.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.877 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -73.39 -29.91 62.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.656 176.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 6' ' ' PRO . 64.4 t -73.58 -48.48 40.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.208 178.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -61.77 -42.18 98.66 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.598 178.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.546 ' CB ' ' HB3' ' A' ' 16' ' ' CYS . 4.9 m120 -115.01 78.7 5.65 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.002 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -64.59 -68.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.715 2.277 . . . . 0.0 113.857 -172.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -98.35 2.03 47.59 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.077 0.465 . . . . 0.0 111.31 -175.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.434 HD12 ' H ' ' A' ' 15' ' ' ILE . 3.0 mp -99.15 -18.09 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.449 177.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.546 ' HB3' ' CB ' ' A' ' 12' ' ' ASN . 21.9 t -140.69 -36.09 0.47 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.598 -172.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.204 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.532 -177.623 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 44.5 m . . . . . 0 N--CA 1.468 0.449 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 p -98.85 15.31 25.9 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.97 0.414 . . . . 0.0 110.961 175.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.1 m80 -128.54 132.79 24.56 Favored Pre-proline 0 CA--C 1.519 -0.213 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.795 -175.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -51.52 -42.35 56.09 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.215 2.61 . . . . 0.0 113.388 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.526 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -65.69 -42.88 90.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.85 0.357 . . . . 0.0 111.3 -179.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.526 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 79.4 m -69.61 -20.58 63.62 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.81 0.338 . . . . 0.0 110.938 178.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -85.57 -23.88 27.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.447 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 7' ' ' ALA . 6.2 p -84.64 -40.12 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.265 -176.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -80.21 -9.27 59.72 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.263 0.554 . . . . 0.0 110.166 175.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.59 ' CB ' ' HB3' ' A' ' 16' ' ' CYS . 68.4 m-80 -137.06 67.05 55.39 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.09 178.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -84.72 -30.5 0.57 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.285 1.99 . . . . 0.0 113.99 -172.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -99.35 -23.26 15.22 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.888 0.375 . . . . 0.0 111.582 -174.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.473 HG13 ' H ' ' A' ' 16' ' ' CYS . 5.2 pt -98.47 -46.77 12.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.481 0.657 . . . . 0.0 110.738 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.59 ' HB3' ' CB ' ' A' ' 12' ' ' ASN . 16.8 t -98.86 -27.53 13.87 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.985 -173.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.399 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.912 177.599 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.3 m . . . . . 0 N--CA 1.461 0.082 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 45.3 m -98.74 18.71 16.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.931 0.395 . . . . 0.0 110.745 176.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.3 m80 -127.09 124.43 23.85 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.604 -174.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.504 ' O ' HG23 ' A' ' 10' ' ' VAL . 61.7 Cg_exo -54.05 -40.0 83.18 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.171 2.58 . . . . 0.0 113.383 -176.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.53 -43.23 97.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.866 0.365 . . . . 0.0 111.27 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.4 m -69.86 -25.01 63.52 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.056 0.455 . . . . 0.0 110.291 178.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -78.75 -13.13 59.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.013 178.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 6' ' ' PRO . 60.5 t -75.01 -52.75 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 175.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.443 HD22 ' N ' ' A' ' 11' ' ' ASN . 2.2 m120 -70.49 -31.71 68.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.559 178.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.531 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 74.7 m-80 -124.63 76.47 63.92 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.649 -178.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.491 ' HD2' HD11 ' A' ' 15' ' ' ILE . 36.6 Cg_endo -75.57 -59.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.64 2.227 . . . . 0.0 114.545 -172.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 24.5 p80 -98.46 -4.76 33.79 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.057 0.456 . . . . 0.0 111.172 -174.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.491 HD11 ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -98.61 -22.84 4.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.575 178.479 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.531 ' HB3' ' HB3' ' A' ' 12' ' ' ASN . 50.7 t -137.92 -17.31 1.24 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.863 -170.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.147 178.03 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 71.6 m . . . . . 0 N--CA 1.462 0.163 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.8 p -98.86 21.11 11.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.042 0.449 . . . . 0.0 110.66 174.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.421 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 2.8 m80 -127.31 131.15 23.7 Favored Pre-proline 0 C--O 1.233 0.193 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.181 -175.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.55 ' O ' HG23 ' A' ' 10' ' ' VAL . 64.9 Cg_exo -53.2 -49.53 17.16 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.0 2.467 . . . . 0.0 113.026 -178.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.56 -39.13 86.84 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.061 -178.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.421 ' SG ' ' HB2' ' A' ' 5' ' ' HIS . 36.8 m -70.32 -29.01 65.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.87 0.367 . . . . 0.0 110.606 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -76.62 -20.18 57.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.291 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 6' ' ' PRO . 57.7 t -69.96 -51.8 36.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.929 0.395 . . . . 0.0 110.427 178.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.408 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 62.1 m-80 -74.69 -32.02 62.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.149 0.5 . . . . 0.0 110.987 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.544 ' O ' ' HB3' ' A' ' 16' ' ' CYS . 74.4 m-80 -120.59 77.19 27.8 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.558 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 11' ' ' ASN . 6.1 Cg_exo -85.28 -42.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.1 2.533 . . . . 0.0 113.912 -172.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -98.05 -16.29 19.66 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.882 0.372 . . . . 0.0 111.362 -174.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.488 HD13 ' H ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -98.66 -27.66 3.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.006 178.349 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.544 ' HB3' ' O ' ' A' ' 12' ' ' ASN . 50.8 t -130.49 -6.69 4.19 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.079 -169.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 C-N-CA 120.166 -1.016 . . . . 0.0 112.262 179.109 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 92.2 m . . . . . 0 N--CA 1.463 0.187 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 p -99.04 18.39 17.44 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.727 0.299 . . . . 0.0 110.66 174.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 14.5 m80 -130.75 136.29 28.7 Favored Pre-proline 0 C--O 1.234 0.238 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.546 -176.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 5' ' ' HIS . 49.2 Cg_exo -56.93 -40.93 80.54 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 123.035 2.49 . . . . 0.0 113.244 -178.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.502 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -69.52 -37.21 77.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.206 -178.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.551 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 80.1 m -71.69 -22.3 61.67 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.793 0.33 . . . . 0.0 110.888 177.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -82.93 -25.2 32.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.93 179.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.502 HG12 ' O ' ' A' ' 7' ' ' ALA . 5.0 p -85.79 -39.62 13.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.361 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.445 HD22 HG13 ' A' ' 10' ' ' VAL . 2.2 m120 -71.02 -16.49 62.62 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.053 0.454 . . . . 0.0 110.345 174.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.619 ' CB ' ' HB3' ' A' ' 16' ' ' CYS . 70.9 m-80 -137.7 77.63 38.7 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.298 -179.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -65.72 -66.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.167 2.578 . . . . 0.0 114.504 -172.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -97.48 -2.41 42.06 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.921 0.391 . . . . 0.0 111.486 -172.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.4 HD13 ' H ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -99.38 -25.82 3.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.893 178.858 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.619 ' HB3' ' CB ' ' A' ' 12' ' ' ASN . 36.9 t -136.52 -28.23 1.01 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.329 -169.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.275 -179.377 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 67.6 m . . . . . 0 N--CA 1.463 0.181 0 CA-C-O 120.706 0.289 . . . . 0.0 111.601 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.2 p -98.71 17.31 19.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.525 175.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.1 m80 -127.64 131.96 24.09 Favored Pre-proline 0 N--CA 1.462 0.125 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.424 -175.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.454 ' O ' HG23 ' A' ' 10' ' ' VAL . 9.8 Cg_endo -57.83 -41.42 69.73 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.195 2.597 . . . . 0.0 113.444 -175.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.18 -42.22 93.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.077 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 58.9 m -66.45 -22.35 66.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.102 0.477 . . . . 0.0 110.648 177.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -85.43 -6.85 59.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.42 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 6' ' ' PRO . 48.4 t -82.12 -55.02 8.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 176.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -75.73 -20.78 58.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.178 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.573 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 71.9 m-20 -125.34 79.56 66.39 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.15 174.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -79.91 -56.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.021 2.481 . . . . 0.0 114.915 -170.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 23.2 p-80 -97.55 -10.11 25.83 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.575 -172.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.593 HD13 ' H ' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -98.3 -31.73 3.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.259 0.552 . . . . 0.0 110.574 179.06 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.573 ' HB3' ' HB3' ' A' ' 12' ' ' ASN . 50.6 t -122.08 -19.07 6.73 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.085 -170.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.399 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.167 178.108 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.9 m . . . . . 0 N--CA 1.467 0.383 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.1 p -99.59 20.44 13.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.808 0.337 . . . . 0.0 111.576 176.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 6.0 m80 -127.48 137.78 31.43 Favored Pre-proline 0 N--CA 1.462 0.166 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.225 -176.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 5' ' ' HIS . 58.2 Cg_exo -54.41 -48.57 20.77 Favored 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 123.033 2.488 . . . . 0.0 113.504 -176.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.426 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -67.92 -36.53 80.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.103 -178.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.599 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 62.5 m -68.75 -29.2 67.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.715 178.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.401 HD22 ' HA ' ' A' ' 9' ' ' ASN . 4.7 m120 -80.15 -30.95 38.97 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.426 HG12 ' O ' ' A' ' 7' ' ' ALA . 9.1 p -78.24 -37.72 22.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.949 -176.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -83.69 -1.17 53.49 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.896 0.379 . . . . 0.0 110.571 175.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.74 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 70.4 m-80 -141.13 71.4 27.89 Favored Pre-proline 0 N--CA 1.467 0.423 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.135 177.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -79.82 -44.57 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.767 2.311 . . . . 0.0 114.479 -170.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 30.2 p-80 -98.34 -15.09 19.87 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.803 0.335 . . . . 0.0 111.413 -174.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.516 HD13 ' H ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -99.3 -30.05 3.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.246 -179.147 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.74 ' HB3' ' HB3' ' A' ' 12' ' ' ASN . 33.7 t -130.06 -22.01 2.91 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.41 -169.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.26 -179.214 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 85.4 m . . . . . 0 N--CA 1.464 0.25 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.1 m -98.55 23.26 8.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.806 0.336 . . . . 0.0 110.737 175.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.0 m80 -132.48 129.4 21.44 Favored Pre-proline 0 C--O 1.233 0.2 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.38 -176.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.422 ' O ' HG23 ' A' ' 10' ' ' VAL . 86.7 Cg_exo -49.04 -43.08 37.31 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.307 2.671 . . . . 0.0 113.475 -177.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.46 -46.39 90.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.362 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.497 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 82.1 m -71.46 -15.72 62.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.749 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -85.19 -30.74 23.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.752 0.31 . . . . 0.0 110.666 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 6' ' ' PRO . 48.8 t -82.99 -48.69 17.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.243 177.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -65.48 -34.08 77.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.256 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.669 ' HB2' ' HB3' ' A' ' 16' ' ' CYS . 6.2 m120 -123.69 79.46 55.92 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.801 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -81.67 -42.88 0.1 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.351 2.034 . . . . 0.0 114.688 -170.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 27.2 p80 -98.56 -13.41 20.44 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.608 -173.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.586 HD13 ' H ' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -101.49 -32.83 3.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.72 176.716 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.669 ' HB3' ' HB2' ' A' ' 12' ' ' ASN . 20.0 t -127.12 2.67 6.46 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.675 -170.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.466 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.237 -179.462 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 95.3 m . . . . . 0 N--CA 1.464 0.247 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.8 p -98.87 18.97 15.83 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.788 175.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.9 m80 -129.99 131.55 23.55 Favored Pre-proline 0 C--O 1.232 0.176 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.229 -177.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.432 ' O ' HG23 ' A' ' 10' ' ' VAL . 77.3 Cg_exo -52.89 -52.93 7.71 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.097 2.531 . . . . 0.0 113.574 -176.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.78 -39.44 94.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.45 -178.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.8 t -64.79 -26.59 68.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.019 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -78.15 -22.96 47.96 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.273 177.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 6' ' ' PRO . 59.9 t -79.17 -48.88 20.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.884 0.373 . . . . 0.0 110.702 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.408 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 62.3 m-80 -73.05 -27.76 61.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.987 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.551 ' CB ' ' HB3' ' A' ' 16' ' ' CYS . 76.9 m-20 -119.58 80.4 23.02 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.824 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 11' ' ' ASN . 1.0 OUTLIER -91.1 -38.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.891 2.394 . . . . 0.0 114.4 -172.486 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 56.1 p-80 -98.53 -12.45 21.22 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.762 -177.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.565 HD13 ' H ' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -101.84 -31.67 3.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.488 176.092 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.551 ' HB3' ' CB ' ' A' ' 12' ' ' ASN . 44.9 t -131.73 17.25 4.75 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.553 -170.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.235 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.167 178.314 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 94.2 m . . . . . 0 N--CA 1.463 0.19 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.1 m -99.79 12.06 37.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.563 0.221 . . . . 0.0 111.048 176.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 8.4 m80 -124.4 127.48 25.26 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.795 -174.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 5' ' ' HIS . 69.4 Cg_exo -55.04 -38.07 93.58 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.271 2.647 . . . . 0.0 113.925 -175.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.676 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -67.9 -43.04 80.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.099 0.476 . . . . 0.0 110.777 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.663 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 52.6 t -70.28 -19.58 63.09 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.621 178.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -83.24 -17.8 41.41 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.676 HG12 ' O ' ' A' ' 7' ' ' ALA . 4.8 p -84.04 -41.18 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.116 -176.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -88.83 -5.79 57.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.006 0.432 . . . . 0.0 110.126 175.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.729 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 74.7 m-20 -135.61 71.45 65.15 Favored Pre-proline 0 N--CA 1.465 0.292 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.199 174.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -85.69 -42.43 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.901 2.401 . . . . 0.0 114.088 -172.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 -98.21 -15.95 19.66 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.044 0.449 . . . . 0.0 111.079 -176.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.511 HD13 ' H ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -99.17 -30.58 3.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.894 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.729 ' HB3' ' HB3' ' A' ' 12' ' ' ASN . 35.4 t -134.63 4.14 3.33 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.479 -170.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.48 0 C-N-CA 120.397 -0.906 . . . . 0.0 111.95 179.151 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.887 0 N-CA-C 111.658 -0.577 . . . . 0.0 111.658 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 11.2 t -102.95 -32.16 9.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 117.064 0.432 . . . . 0.0 110.503 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 87.2 m -64.58 -2.66 2.51 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.5 p -99.06 24.47 7.79 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.703 0.287 . . . . 0.0 111.739 177.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -134.88 129.4 19.17 Favored Pre-proline 0 C--O 1.232 0.174 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.354 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.425 ' O ' HG23 ' A' ' 10' ' ' VAL . 9.2 Cg_endo -54.88 -37.1 93.03 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.104 2.536 . . . . 0.0 113.124 -178.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.57 -36.62 70.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.882 0.372 . . . . 0.0 111.18 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.525 ' HA ' HD21 ' A' ' 11' ' ' ASN . 45.7 t -72.93 -19.2 61.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.601 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -82.55 -11.31 58.54 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.081 176.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 6' ' ' PRO . 55.1 t -79.47 -53.08 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.716 0.293 . . . . 0.0 110.459 177.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.525 HD21 ' HA ' ' A' ' 8' ' ' CYS . 9.6 p30 -74.09 -26.71 60.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.05 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.708 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 72.6 m-20 -119.68 78.93 22.41 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.738 174.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 11' ' ' ASN . 10.1 Cg_exo -77.9 -59.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.924 2.416 . . . . 0.0 114.475 -170.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -97.92 -6.62 31.88 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.508 -172.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.582 HD13 ' H ' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -99.37 -30.72 3.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.857 176.858 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.708 ' HB3' ' HB3' ' A' ' 12' ' ' ASN . 52.4 t -127.35 -15.83 5.06 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.173 -170.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.33 -27.68 3.3 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.357 -0.925 . . . . 0.0 111.819 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.554 0 O-C-N 121.913 -0.757 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.929 0 N-CA-C 111.961 -0.455 . . . . 0.0 111.961 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 4.8 p 40.13 51.87 2.69 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.395 0.678 . . . . 0.0 112.382 178.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 97.0 m -75.99 0.15 19.53 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -177.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.4 p -99.65 16.66 22.75 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.143 0.497 . . . . 0.0 110.408 173.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -125.77 130.55 24.01 Favored Pre-proline 0 C--O 1.233 0.227 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.049 -175.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.444 ' O ' HG23 ' A' ' 10' ' ' VAL . 6.5 Cg_endo -52.34 -46.27 34.02 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.325 2.684 . . . . 0.0 113.518 -175.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.98 -44.97 94.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.838 0.351 . . . . 0.0 111.456 -178.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.49 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 11.9 m -71.9 -15.78 62.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.243 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -85.51 -25.69 26.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.664 0.268 . . . . 0.0 111.002 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 6' ' ' PRO . 62.0 t -82.08 -52.44 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.367 178.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.418 ' N ' HD22 ' A' ' 11' ' ' ASN . 2.6 m120 -67.43 -31.18 71.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.564 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.656 ' HB2' ' HB3' ' A' ' 16' ' ' CYS . 5.1 m120 -119.4 77.29 18.6 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 177.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -83.57 -42.19 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.375 2.05 . . . . 0.0 115.088 -168.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 34.1 p-80 -98.38 -16.36 19.33 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.223 0.535 . . . . 0.0 110.96 -175.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.539 HD13 ' H ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -98.3 -28.71 3.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.079 -179.461 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.656 ' HB3' ' HB2' ' A' ' 12' ' ' ASN . 42.6 t -130.36 -26.9 2.26 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.379 -169.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.05 -128.61 4.93 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.249 -0.977 . . . . 0.0 112.339 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.547 0 O-C-N 121.911 -0.758 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.817 0 N-CA-C 112.121 -0.392 . . . . 0.0 112.121 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 2.6 p -134.17 53.84 1.98 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.12 0.486 . . . . 0.0 110.481 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 55.8 m -71.18 -0.16 9.13 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.1 m -98.74 17.04 20.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.131 0.491 . . . . 0.0 110.36 175.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -128.33 128.58 23.65 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.021 -175.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.515 ' O ' HG23 ' A' ' 10' ' ' VAL . 52.4 Cg_exo -56.06 -42.31 67.85 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.878 2.385 . . . . 0.0 113.166 -176.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.04 -42.86 99.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.971 0.415 . . . . 0.0 111.328 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 66.1 m -68.93 -25.13 64.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.899 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -77.93 -29.95 50.23 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.619 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 6' ' ' PRO . 85.7 t -68.03 -50.14 61.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.113 0.483 . . . . 0.0 109.878 175.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.409 HD22 ' N ' ' A' ' 11' ' ' ASN . 2.3 m120 -68.25 -30.08 69.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.111 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.556 ' O ' ' HB3' ' A' ' 16' ' ' CYS . 69.2 m-80 -125.6 78.42 68.6 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.719 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -89.2 -26.47 0.46 Allowed 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 122.49 2.127 . . . . 0.0 114.31 -173.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.446 ' ND1' HG23 ' A' ' 15' ' ' ILE . 18.1 p80 -100.01 -26.61 13.92 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.882 0.372 . . . . 0.0 111.95 -173.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.446 HG23 ' ND1' ' A' ' 14' ' ' HIS . 4.1 pt -99.46 -34.39 4.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.257 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.556 ' HB3' ' O ' ' A' ' 12' ' ' ASN . 40.6 t -111.34 -64.19 1.31 Allowed 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.938 -1.028 . . . . 0.0 112.154 -166.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -140.15 79.29 0.29 Allowed Glycine 0 C--N 1.318 -0.421 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.662 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.553 0 O-C-N 121.755 -0.85 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.915 0 N-CA-C 112.1 -0.4 . . . . 0.0 112.1 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 12.6 t -67.78 -29.57 68.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.767 0.318 . . . . 0.0 110.487 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 86.3 m -71.19 6.71 1.54 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.6 t -98.93 15.12 26.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.987 0.422 . . . . 0.0 110.101 175.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -129.61 132.53 24.27 Favored Pre-proline 0 CA--C 1.518 -0.258 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.544 -175.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.588 ' O ' HG23 ' A' ' 10' ' ' VAL . 51.7 Cg_exo -55.6 -47.11 27.24 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.927 2.418 . . . . 0.0 112.996 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.51 -40.02 95.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.855 0.359 . . . . 0.0 111.398 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.6 t -69.61 -27.17 64.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.736 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -77.37 -23.86 50.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.87 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 6' ' ' PRO . 72.2 t -77.3 -50.93 19.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.778 0.323 . . . . 0.0 110.23 177.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.44 ' N ' HD22 ' A' ' 11' ' ' ASN . 2.2 m120 -69.24 -27.73 65.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.75 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.545 ' CB ' ' HB3' ' A' ' 16' ' ' CYS . 74.6 m-20 -122.21 77.14 42.92 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.482 177.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -87.49 -38.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.185 1.923 . . . . 0.0 114.978 -168.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -98.77 -9.21 24.77 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.376 0.608 . . . . 0.0 111.276 -174.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.9 pt -108.45 -41.02 4.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.583 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.545 ' HB3' ' CB ' ' A' ' 12' ' ' ASN . 44.7 t -115.04 -26.99 7.5 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.583 -170.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -99.37 -174.16 31.25 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.378 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.647 0 CA-C-N 117.737 0.768 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.885 0 N-CA-C 112.371 -0.292 . . . . 0.0 112.371 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.8 p -132.15 39.13 3.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.003 0.43 . . . . 0.0 110.783 178.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 84.8 m -73.37 -9.6 58.87 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 54.9 m -98.51 23.79 8.15 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.123 0.487 . . . . 0.0 110.574 174.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.455 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . 9.6 m80 -130.37 118.21 18.06 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.829 -176.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 5' ' ' HIS . 3.8 Cg_endo -51.01 -47.05 27.46 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.441 2.761 . . . . 0.0 113.631 -174.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.02 -41.43 95.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.798 0.333 . . . . 0.0 111.215 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.645 ' HA ' HD21 ' A' ' 11' ' ' ASN . 39.8 t -66.82 -26.38 66.9 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.167 178.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -72.83 -15.11 61.63 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.672 0.272 . . . . 0.0 111.122 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.422 ' O ' ' HG3' ' A' ' 13' ' ' PRO . 59.6 t -83.28 -49.05 17.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.621 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.645 HD21 ' HA ' ' A' ' 8' ' ' CYS . 11.7 p30 -78.75 -21.54 47.81 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.816 0.341 . . . . 0.0 110.86 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.678 ' HB3' ' CB ' ' A' ' 16' ' ' CYS . 37.4 m-20 -122.23 74.81 40.83 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.156 174.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.472 ' O ' ' N ' ' A' ' 18' ' ' NH2 . 10.3 Cg_exo -77.55 -58.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.028 2.486 . . . . 0.0 113.946 -172.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 49.6 p-80 -98.38 -12.45 21.42 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.481 -175.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.573 HD12 ' H ' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -97.97 -2.74 9.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.914 0.388 . . . . 0.0 110.27 -179.194 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.678 ' CB ' ' HB3' ' A' ' 12' ' ' ASN . 52.5 t -143.83 -67.98 0.34 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.079 -175.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -98.57 18.18 57.32 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.005 -1.093 . . . . 0.0 112.663 -175.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' NH2 . . . . . 0.472 ' N ' ' O ' ' A' ' 13' ' ' PRO . . . . . . . . 0 C--N 1.32 -0.676 0 O-C-N 121.81 -0.818 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.761 0 N-CA-C 112.097 -0.401 . . . . 0.0 112.097 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 4.6 p -115.57 50.41 1.01 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.958 0.408 . . . . 0.0 110.77 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 67.9 m -71.52 7.47 1.4 Allowed 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.0 t -99.17 5.71 46.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.055 0.455 . . . . 0.0 110.226 175.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 8.0 m80 -121.62 132.82 24.15 Favored Pre-proline 0 C--O 1.232 0.134 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.715 -174.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 5' ' ' HIS . 54.0 Cg_exo -54.8 -39.63 88.86 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.176 2.584 . . . . 0.0 113.501 -177.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.496 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -65.73 -39.5 91.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.887 0.375 . . . . 0.0 111.262 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.509 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 46.9 m -73.2 -23.11 60.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.532 178.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -85.12 -22.85 28.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.292 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.496 HG12 ' O ' ' A' ' 7' ' ' ALA . 6.2 p -85.67 -36.11 10.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.723 0.297 . . . . 0.0 110.451 -178.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.43 HD22 ' N ' ' A' ' 11' ' ' ASN . 2.2 m120 -74.61 -20.12 60.04 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 173.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.674 ' CB ' ' HB3' ' A' ' 16' ' ' CYS . 73.0 m-80 -135.41 73.64 62.58 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.678 -177.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -76.8 -43.26 0.27 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.827 2.351 . . . . 0.0 114.309 -173.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 -97.77 -17.02 19.61 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -173.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.504 HG12 ' HB3' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -99.38 -30.58 3.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.098 0.475 . . . . 0.0 110.966 179.492 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.674 ' HB3' ' CB ' ' A' ' 12' ' ' ASN . 43.5 t -130.63 -3.38 4.2 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.832 -170.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -110.18 -176.73 20.92 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.262 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.643 0 CA-C-N 117.648 0.724 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.666 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.528 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 2.9 p 39.75 53.13 2.54 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.65 0.78 . . . . 0.0 112.956 178.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 69.6 m -75.82 1.73 14.15 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.5 t -99.43 18.27 18.2 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.265 0.555 . . . . 0.0 109.61 174.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.2 m80 -131.3 123.24 19.51 Favored Pre-proline 0 C--N 1.334 -0.095 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.36 -174.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.423 ' O ' HG23 ' A' ' 10' ' ' VAL . 79.5 Cg_exo -49.26 -42.51 40.01 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.305 2.67 . . . . 0.0 113.322 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.64 -46.48 87.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.197 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.58 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 24.3 m -76.35 -11.99 59.99 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.29 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -83.78 -32.71 25.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.894 0.378 . . . . 0.0 110.172 177.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 6' ' ' PRO . 51.2 t -84.86 -46.86 17.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.52 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.418 ' N ' HD22 ' A' ' 11' ' ' ASN . 2.4 m120 -69.04 -32.69 72.36 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.096 0.474 . . . . 0.0 110.364 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.608 ' HB2' ' HB3' ' A' ' 16' ' ' CYS . 7.2 m120 -118.09 77.72 12.76 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.422 176.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -88.57 -33.65 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.23 1.954 . . . . 0.0 114.323 -170.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -98.41 -13.29 20.68 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.353 -175.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.623 HD13 ' H ' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -106.97 -32.1 2.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.195 0.521 . . . . 0.0 110.695 176.047 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.608 ' HB3' ' HB2' ' A' ' 12' ' ' ASN . 34.9 t -126.56 11.35 7.34 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.658 -169.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -135.67 -37.03 0.2 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.403 -0.904 . . . . 0.0 112.035 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.53 0 O-C-N 121.799 -0.824 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.897 0 N-CA-C 111.746 -0.542 . . . . 0.0 111.746 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.417 ' HA ' ' NE2' ' A' ' 5' ' ' HIS . 7.6 t -81.79 -19.41 41.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 117.252 0.526 . . . . 0.0 109.678 177.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 80.2 m -77.63 17.5 0.53 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.994 175.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.0 m -104.8 6.52 34.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.249 176.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.417 ' NE2' ' HA ' ' A' ' 2' ' ' CYS . 0.9 OUTLIER -127.82 133.37 25.04 Favored Pre-proline 0 C--O 1.232 0.14 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 -176.046 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.543 ' O ' HG23 ' A' ' 10' ' ' VAL . 24.3 Cg_endo -61.64 -34.17 84.9 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.381 2.054 . . . . 0.0 112.036 177.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.85 -44.95 79.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.123 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 47.1 t -68.52 -27.33 66.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.574 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -71.68 -22.06 61.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.846 176.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 6' ' ' PRO . 93.7 t -73.47 -51.34 25.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.73 0.3 . . . . 0.0 110.346 176.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.451 HD22 ' N ' ' A' ' 11' ' ' ASN . 2.1 m120 -71.02 -31.86 68.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.201 0.524 . . . . 0.0 110.526 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.583 ' O ' ' HB3' ' A' ' 16' ' ' CYS . 74.4 m-80 -119.56 77.5 20.08 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.401 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -90.13 -36.74 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.73 2.287 . . . . 0.0 114.057 -174.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 32.5 p-80 -99.79 -17.63 17.58 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.848 0.356 . . . . 0.0 111.314 -176.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.524 HD13 ' H ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -99.38 -31.95 3.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.31 0.576 . . . . 0.0 111.127 -179.307 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.583 ' HB3' ' O ' ' A' ' 12' ' ' ASN . 36.2 t -116.02 -74.58 0.6 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.835 -170.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -137.21 94.13 0.22 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.421 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.581 0 O-C-N 121.932 -0.746 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.884 0 N-CA-C 111.932 -0.467 . . . . 0.0 111.932 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.444 ' HA ' ' NE2' ' A' ' 5' ' ' HIS . 31.6 t -90.03 -13.75 35.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.003 0.43 . . . . 0.0 110.554 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 75.4 m -75.17 10.77 1.38 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.826 0.346 . . . . 0.0 111.486 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 37.2 m -99.9 8.19 44.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.071 177.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.444 ' NE2' ' HA ' ' A' ' 2' ' ' CYS . 1.2 m-70 -125.11 134.37 25.67 Favored Pre-proline 0 C--O 1.232 0.161 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 -175.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.446 ' O ' HG23 ' A' ' 10' ' ' VAL . 70.4 Cg_exo -52.43 -53.02 7.61 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.062 2.508 . . . . 0.0 113.497 -177.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.09 -38.05 87.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.661 -178.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.0 t -68.12 -28.55 67.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.872 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -75.07 -22.37 58.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.326 177.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 6' ' ' PRO . 56.1 t -77.64 -56.47 7.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.854 0.359 . . . . 0.0 110.581 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -66.83 -24.87 66.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.88 0.372 . . . . 0.0 111.16 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.487 ' CB ' ' HB3' ' A' ' 16' ' ' CYS . 73.5 m-80 -122.88 78.62 49.82 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.12 178.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -96.3 -25.73 0.1 Allowed 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.663 2.242 . . . . 0.0 115.081 -170.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -98.46 -21.82 16.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.29 0.567 . . . . 0.0 111.093 -176.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.5 pt -105.22 -37.07 3.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.643 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.487 ' HB3' ' CB ' ' A' ' 12' ' ' ASN . 42.8 t -117.68 -12.18 10.31 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.746 -1.115 . . . . 0.0 111.05 -170.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -99.65 168.19 21.47 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.248 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.642 0 CA-C-N 117.738 0.769 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.845 0 N-CA-C 112.601 -0.2 . . . . 0.0 112.601 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.8 t -63.52 -26.05 68.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.895 0.378 . . . . 0.0 110.558 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 72.1 m -67.1 -2.95 6.25 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.2 t -98.63 22.84 9.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.999 0.428 . . . . 0.0 110.291 177.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.405 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . 15.4 m80 -131.74 124.21 19.7 Favored Pre-proline 0 C--O 1.231 0.089 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.24 -176.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 5' ' ' HIS . 10.0 Cg_endo -55.41 -40.48 85.3 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.149 2.566 . . . . 0.0 113.54 -176.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.49 -34.39 70.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.846 0.355 . . . . 0.0 110.873 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 42.6 t -71.03 -24.4 62.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.173 0.511 . . . . 0.0 110.666 178.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -79.52 -12.3 59.87 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.136 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.7 t -77.42 -58.34 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.731 0.3 . . . . 0.0 110.369 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -76.04 -12.13 60.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.819 0.343 . . . . 0.0 111.152 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.656 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 82.3 m-20 -128.55 72.42 80.71 Favored Pre-proline 0 N--CA 1.465 0.285 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.133 174.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -83.16 -43.84 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.43 2.086 . . . . 0.0 114.913 -170.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -97.74 -19.0 18.49 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.909 0.385 . . . . 0.0 111.915 -171.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.9 pt -99.07 -32.35 3.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.041 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.656 ' HB3' ' HB3' ' A' ' 12' ' ' ASN . 22.3 t -127.67 -13.05 5.4 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.508 -169.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -99.82 -59.98 0.85 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.344 -0.931 . . . . 0.0 112.454 -177.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.532 0 O-C-N 121.907 -0.761 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.861 0 N-CA-C 111.809 -0.516 . . . . 0.0 111.809 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 13.1 t -116.25 -33.82 4.86 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 177.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 87.8 m -70.93 5.98 1.75 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 178.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.5 p -98.96 14.72 28.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.939 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.428 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 21.9 m80 -131.26 142.73 46.52 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.926 -176.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.518 ' O ' HG23 ' A' ' 10' ' ' VAL . 46.6 Cg_exo -57.71 -51.13 8.74 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.9 2.4 . . . . 0.0 113.21 -178.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.22 -45.69 92.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.744 -177.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.3 t -64.92 -28.23 69.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.877 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -73.39 -29.91 62.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.656 176.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 6' ' ' PRO . 64.4 t -73.58 -48.48 40.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.208 178.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -61.77 -42.18 98.66 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.598 178.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.546 ' CB ' ' HB3' ' A' ' 16' ' ' CYS . 4.9 m120 -115.01 78.7 5.65 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.002 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -64.59 -68.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.715 2.277 . . . . 0.0 113.857 -172.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -98.35 2.03 47.59 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.077 0.465 . . . . 0.0 111.31 -175.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.434 HD12 ' H ' ' A' ' 15' ' ' ILE . 3.0 mp -99.15 -18.09 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.449 177.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.546 ' HB3' ' CB ' ' A' ' 12' ' ' ASN . 21.9 t -140.69 -36.09 0.47 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.598 -172.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -98.85 -137.16 9.66 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.532 -177.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.539 0 O-C-N 121.783 -0.833 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.908 0 N-CA-C 111.946 -0.462 . . . . 0.0 111.946 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.3 p -147.73 40.08 0.98 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.9 0.381 . . . . 0.0 110.416 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 44.5 m -67.77 5.15 0.91 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 p -98.85 15.31 25.9 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.97 0.414 . . . . 0.0 110.961 175.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.1 m80 -128.54 132.79 24.56 Favored Pre-proline 0 CA--C 1.519 -0.213 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.795 -175.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -51.52 -42.35 56.09 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.215 2.61 . . . . 0.0 113.388 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.526 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -65.69 -42.88 90.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.85 0.357 . . . . 0.0 111.3 -179.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.526 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 79.4 m -69.61 -20.58 63.62 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.81 0.338 . . . . 0.0 110.938 178.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -85.57 -23.88 27.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.447 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 7' ' ' ALA . 6.2 p -84.64 -40.12 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.265 -176.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -80.21 -9.27 59.72 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.263 0.554 . . . . 0.0 110.166 175.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.59 ' CB ' ' HB3' ' A' ' 16' ' ' CYS . 68.4 m-80 -137.06 67.05 55.39 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.09 178.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -84.72 -30.5 0.57 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.285 1.99 . . . . 0.0 113.99 -172.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -99.35 -23.26 15.22 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.888 0.375 . . . . 0.0 111.582 -174.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.473 HG13 ' H ' ' A' ' 16' ' ' CYS . 5.2 pt -98.47 -46.77 12.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.481 0.657 . . . . 0.0 110.738 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.59 ' HB3' ' CB ' ' A' ' 12' ' ' ASN . 16.8 t -98.86 -27.53 13.87 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.985 -173.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -99.85 -9.23 49.83 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.912 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.478 0 O-C-N 121.698 -0.884 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.913 0 N-CA-C 112.276 -0.33 . . . . 0.0 112.276 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.8 p 40.36 55.91 2.73 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.795 0.838 . . . . 0.0 112.578 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.3 m -75.15 -4.5 39.11 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 45.3 m -98.74 18.71 16.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.931 0.395 . . . . 0.0 110.745 176.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.3 m80 -127.09 124.43 23.85 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.604 -174.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.504 ' O ' HG23 ' A' ' 10' ' ' VAL . 61.7 Cg_exo -54.05 -40.0 83.18 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.171 2.58 . . . . 0.0 113.383 -176.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.53 -43.23 97.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.866 0.365 . . . . 0.0 111.27 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.4 m -69.86 -25.01 63.52 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.056 0.455 . . . . 0.0 110.291 178.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -78.75 -13.13 59.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.013 178.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 6' ' ' PRO . 60.5 t -75.01 -52.75 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 175.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.443 HD22 ' N ' ' A' ' 11' ' ' ASN . 2.2 m120 -70.49 -31.71 68.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.559 178.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.531 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 74.7 m-80 -124.63 76.47 63.92 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.649 -178.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.491 ' HD2' HD11 ' A' ' 15' ' ' ILE . 36.6 Cg_endo -75.57 -59.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.64 2.227 . . . . 0.0 114.545 -172.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 24.5 p80 -98.46 -4.76 33.79 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.057 0.456 . . . . 0.0 111.172 -174.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.491 HD11 ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -98.61 -22.84 4.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.575 178.479 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.531 ' HB3' ' HB3' ' A' ' 12' ' ' ASN . 50.7 t -137.92 -17.31 1.24 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.863 -170.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -104.31 -130.31 6.81 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.147 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.529 0 CA-C-N 117.924 0.862 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.835 0 N-CA-C 111.788 -0.525 . . . . 0.0 111.788 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 7.9 p 39.26 50.94 2.02 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.562 0.745 . . . . 0.0 112.579 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 71.6 m -72.0 -2.06 16.85 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -177.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.8 p -98.86 21.11 11.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.042 0.449 . . . . 0.0 110.66 174.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.421 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 2.8 m80 -127.31 131.15 23.7 Favored Pre-proline 0 C--O 1.233 0.193 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.181 -175.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.55 ' O ' HG23 ' A' ' 10' ' ' VAL . 64.9 Cg_exo -53.2 -49.53 17.16 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.0 2.467 . . . . 0.0 113.026 -178.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.56 -39.13 86.84 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.061 -178.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.421 ' SG ' ' HB2' ' A' ' 5' ' ' HIS . 36.8 m -70.32 -29.01 65.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.87 0.367 . . . . 0.0 110.606 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -76.62 -20.18 57.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.291 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 6' ' ' PRO . 57.7 t -69.96 -51.8 36.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.929 0.395 . . . . 0.0 110.427 178.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.408 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 62.1 m-80 -74.69 -32.02 62.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.149 0.5 . . . . 0.0 110.987 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.544 ' O ' ' HB3' ' A' ' 16' ' ' CYS . 74.4 m-80 -120.59 77.19 27.8 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.558 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 11' ' ' ASN . 6.1 Cg_exo -85.28 -42.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.1 2.533 . . . . 0.0 113.912 -172.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -98.05 -16.29 19.66 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.882 0.372 . . . . 0.0 111.362 -174.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.488 HD13 ' H ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -98.66 -27.66 3.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.006 178.349 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.544 ' HB3' ' O ' ' A' ' 12' ' ' ASN . 50.8 t -130.49 -6.69 4.19 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.079 -169.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -99.84 -53.48 1.11 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.166 -1.016 . . . . 0.0 112.262 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.589 0 O-C-N 121.846 -0.796 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.74 0 N-CA-C 112.102 -0.399 . . . . 0.0 112.102 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.6 p -133.62 45.87 2.62 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.915 0.388 . . . . 0.0 110.664 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 92.2 m -70.76 5.81 1.77 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 p -99.04 18.39 17.44 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.727 0.299 . . . . 0.0 110.66 174.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 14.5 m80 -130.75 136.29 28.7 Favored Pre-proline 0 C--O 1.234 0.238 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.546 -176.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 5' ' ' HIS . 49.2 Cg_exo -56.93 -40.93 80.54 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 123.035 2.49 . . . . 0.0 113.244 -178.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.502 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -69.52 -37.21 77.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.206 -178.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.551 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 80.1 m -71.69 -22.3 61.67 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.793 0.33 . . . . 0.0 110.888 177.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -82.93 -25.2 32.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.93 179.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.502 HG12 ' O ' ' A' ' 7' ' ' ALA . 5.0 p -85.79 -39.62 13.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.361 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.445 HD22 HG13 ' A' ' 10' ' ' VAL . 2.2 m120 -71.02 -16.49 62.62 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.053 0.454 . . . . 0.0 110.345 174.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.619 ' CB ' ' HB3' ' A' ' 16' ' ' CYS . 70.9 m-80 -137.7 77.63 38.7 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.298 -179.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -65.72 -66.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.167 2.578 . . . . 0.0 114.504 -172.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -97.48 -2.41 42.06 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.921 0.391 . . . . 0.0 111.486 -172.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.4 HD13 ' H ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -99.38 -25.82 3.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.893 178.858 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.619 ' HB3' ' CB ' ' A' ' 12' ' ' ASN . 36.9 t -136.52 -28.23 1.01 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.329 -169.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -105.16 13.27 48.67 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.275 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.513 0 O-C-N 121.972 -0.722 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.609 0 N-CA-C 111.933 -0.467 . . . . 0.0 111.933 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 23.6 p 41.83 45.86 3.25 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.675 0.79 . . . . 0.0 112.529 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 67.6 m -73.82 0.62 12.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.706 0.289 . . . . 0.0 111.601 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.2 p -98.71 17.31 19.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.525 175.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.1 m80 -127.64 131.96 24.09 Favored Pre-proline 0 N--CA 1.462 0.125 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.424 -175.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.454 ' O ' HG23 ' A' ' 10' ' ' VAL . 9.8 Cg_endo -57.83 -41.42 69.73 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.195 2.597 . . . . 0.0 113.444 -175.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.18 -42.22 93.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.077 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 58.9 m -66.45 -22.35 66.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.102 0.477 . . . . 0.0 110.648 177.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -85.43 -6.85 59.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.42 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 6' ' ' PRO . 48.4 t -82.12 -55.02 8.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 176.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -75.73 -20.78 58.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.178 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.573 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 71.9 m-20 -125.34 79.56 66.39 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.15 174.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -79.91 -56.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.021 2.481 . . . . 0.0 114.915 -170.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 23.2 p-80 -97.55 -10.11 25.83 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.575 -172.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.593 HD13 ' H ' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -98.3 -31.73 3.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.259 0.552 . . . . 0.0 110.574 179.06 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.573 ' HB3' ' HB3' ' A' ' 12' ' ' ASN . 50.6 t -122.08 -19.07 6.73 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.085 -170.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -118.35 -18.07 5.07 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.167 178.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.533 0 O-C-N 121.908 -0.76 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.806 0 N-CA-C 111.921 -0.472 . . . . 0.0 111.921 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 4.4 p -119.9 49.95 1.33 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.844 0.354 . . . . 0.0 111.036 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.9 m -64.66 -2.42 2.43 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.1 p -99.59 20.44 13.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.808 0.337 . . . . 0.0 111.576 176.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 6.0 m80 -127.48 137.78 31.43 Favored Pre-proline 0 N--CA 1.462 0.166 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.225 -176.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 5' ' ' HIS . 58.2 Cg_exo -54.41 -48.57 20.77 Favored 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 123.033 2.488 . . . . 0.0 113.504 -176.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.426 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -67.92 -36.53 80.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.103 -178.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.599 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 62.5 m -68.75 -29.2 67.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.715 178.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.401 HD22 ' HA ' ' A' ' 9' ' ' ASN . 4.7 m120 -80.15 -30.95 38.97 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.426 HG12 ' O ' ' A' ' 7' ' ' ALA . 9.1 p -78.24 -37.72 22.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.949 -176.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -83.69 -1.17 53.49 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.896 0.379 . . . . 0.0 110.571 175.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.74 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 70.4 m-80 -141.13 71.4 27.89 Favored Pre-proline 0 N--CA 1.467 0.423 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.135 177.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -79.82 -44.57 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.767 2.311 . . . . 0.0 114.479 -170.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 30.2 p-80 -98.34 -15.09 19.87 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.803 0.335 . . . . 0.0 111.413 -174.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.516 HD13 ' H ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -99.3 -30.05 3.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.246 -179.147 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.74 ' HB3' ' HB3' ' A' ' 12' ' ' ASN . 33.7 t -130.06 -22.01 2.91 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.41 -169.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -99.31 178.02 30.12 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.26 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.562 0 CA-C-N 117.902 0.851 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.871 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.6 p -140.81 33.41 1.79 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.779 0.323 . . . . 0.0 110.903 178.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 85.4 m -70.63 -0.48 8.77 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -178.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.1 m -98.55 23.26 8.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.806 0.336 . . . . 0.0 110.737 175.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.0 m80 -132.48 129.4 21.44 Favored Pre-proline 0 C--O 1.233 0.2 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.38 -176.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.422 ' O ' HG23 ' A' ' 10' ' ' VAL . 86.7 Cg_exo -49.04 -43.08 37.31 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.307 2.671 . . . . 0.0 113.475 -177.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.46 -46.39 90.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.362 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.497 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 82.1 m -71.46 -15.72 62.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.749 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -85.19 -30.74 23.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.752 0.31 . . . . 0.0 110.666 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 6' ' ' PRO . 48.8 t -82.99 -48.69 17.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.243 177.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -65.48 -34.08 77.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.256 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.669 ' HB2' ' HB3' ' A' ' 16' ' ' CYS . 6.2 m120 -123.69 79.46 55.92 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.801 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -81.67 -42.88 0.1 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.351 2.034 . . . . 0.0 114.688 -170.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 27.2 p80 -98.56 -13.41 20.44 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.608 -173.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.586 HD13 ' H ' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -101.49 -32.83 3.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.72 176.716 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.669 ' HB3' ' HB2' ' A' ' 12' ' ' ASN . 20.0 t -127.12 2.67 6.46 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.675 -170.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -111.8 -46.98 0.75 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.237 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.504 0 O-C-N 121.822 -0.811 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.944 0 N-CA-C 112.05 -0.42 . . . . 0.0 112.05 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.7 t -123.58 -19.96 5.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.882 0.372 . . . . 0.0 110.263 178.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 95.3 m -72.32 6.06 2.51 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -177.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.8 p -98.87 18.97 15.83 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.788 175.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.9 m80 -129.99 131.55 23.55 Favored Pre-proline 0 C--O 1.232 0.176 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.229 -177.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.432 ' O ' HG23 ' A' ' 10' ' ' VAL . 77.3 Cg_exo -52.89 -52.93 7.71 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.097 2.531 . . . . 0.0 113.574 -176.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.78 -39.44 94.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.45 -178.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.8 t -64.79 -26.59 68.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.019 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -78.15 -22.96 47.96 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.273 177.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 6' ' ' PRO . 59.9 t -79.17 -48.88 20.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.884 0.373 . . . . 0.0 110.702 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.408 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 62.3 m-80 -73.05 -27.76 61.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.987 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.551 ' CB ' ' HB3' ' A' ' 16' ' ' CYS . 76.9 m-20 -119.58 80.4 23.02 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.824 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 11' ' ' ASN . 1.0 OUTLIER -91.1 -38.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.891 2.394 . . . . 0.0 114.4 -172.486 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 56.1 p-80 -98.53 -12.45 21.22 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.762 -177.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.565 HD13 ' H ' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -101.84 -31.67 3.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.488 176.092 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.551 ' HB3' ' CB ' ' A' ' 12' ' ' ASN . 44.9 t -131.73 17.25 4.75 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.553 -170.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -99.08 -113.76 3.43 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.167 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.569 0 O-C-N 121.72 -0.871 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.825 0 N-CA-C 111.926 -0.469 . . . . 0.0 111.926 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.428 ' O ' ' HB3' ' A' ' 8' ' ' CYS . 2.0 p -139.7 30.38 2.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.841 0.353 . . . . 0.0 111.382 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 94.2 m -69.6 -4.04 17.55 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.1 m -99.79 12.06 37.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.563 0.221 . . . . 0.0 111.048 176.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 8.4 m80 -124.4 127.48 25.26 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.795 -174.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 5' ' ' HIS . 69.4 Cg_exo -55.04 -38.07 93.58 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.271 2.647 . . . . 0.0 113.925 -175.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.676 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -67.9 -43.04 80.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.099 0.476 . . . . 0.0 110.777 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.663 ' O ' ' HB2' ' A' ' 12' ' ' ASN . 52.6 t -70.28 -19.58 63.09 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.621 178.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -83.24 -17.8 41.41 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.676 HG12 ' O ' ' A' ' 7' ' ' ALA . 4.8 p -84.04 -41.18 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.116 -176.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -88.83 -5.79 57.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.006 0.432 . . . . 0.0 110.126 175.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.729 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 74.7 m-20 -135.61 71.45 65.15 Favored Pre-proline 0 N--CA 1.465 0.292 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.199 174.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -85.69 -42.43 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.901 2.401 . . . . 0.0 114.088 -172.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 -98.21 -15.95 19.66 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.044 0.449 . . . . 0.0 111.079 -176.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.511 HD13 ' H ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -99.17 -30.58 3.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.894 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.729 ' HB3' ' HB3' ' A' ' 12' ' ' ASN . 35.4 t -134.63 4.14 3.33 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.479 -170.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -99.25 15.52 60.2 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.397 -0.906 . . . . 0.0 111.95 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.557 0 O-C-N 121.978 -0.719 . . . . 0.0 . . . . . . . . . . 0 0 . 1 stop_ save_